View
2
Download
0
Category
Preview:
Citation preview
Revised 03/04/2015
CURRICULUM VITAE - KATHLEEN B. SCHWARZ, M.D.
I. PERSONAL DATA
NAME: Kathleen Ann Brogan Schwarz, M.D.
II. EDUCATION AND PROFESSIONAL TRAINING
Years Institution Degree
1960-1964 Scripps College BA Biology
Claremont, CA
1964-1965 Northwestern University MAT Biology
Evanston, IL & French
1968-1970 Universidad Central de Venezuela
Facultad de Medicine, Caracas
Venezuela
1967-1972 Washington University MD
School of Medicine
St. Louis, MO
1972-1973 Intern in Pediatrics
St. Louis Children's Hospital
Washington University School of Medicine
1973-1974 Second Year Assistant Resident in Pediatrics St. Louis Children's Hospital
1974-1976 Fellow in Pediatric Gastroenterology and Nutrition St. Louis Children's Hospital
(half-time)
1976-1977 National Institute of Health Trainee in Medicine (Gastroenterology) Barnes
Hospital, Washington University School of Medicine, St. Louis, MO
-2-
III. PROFESSIONAL EXPERIENCE
1977-1978 Instructor in Pediatric Gastroenterology, Washington University,
Department of Pediatrics, St. Louis Children's Hospital
1977-1978 Instructor in Medicine, Washington University Department of Internal
Medicine Barnes Hospital
1978-1983 Assistant Professor of Pediatrics, Chairman, Division of Pediatric
Gastroenterology, St. Louis University School of Medicine
1983-1987 Associate Professor of Pediatrics, Chairman, Division of Pediatric
Gastroenterology, St. Louis University School of Medicine
1978-1987 Member, full-time staff, Cardinal Glennon Children's Hospital
1978-1987 Member, Medical Staff, St. Louis University Hospital
1987-1989 Assistant Professor of Pediatrics, Division of Pediatric Gastroenterology
and Nutrition, Johns Hopkins University School of Medicine
1987-1992 Member, full-time staff, University of Maryland Medical Systems
1989-Present Associate Professor of Pediatrics, Division of Pediatric Gastroenterology and
Nutrition, Johns Hopkins University School of Medicine
1995-1998 Acting Chief, Division of Pediatric Gastroenterology and Nutrition,
Johns Hopkins University School of Medicine
1998 - 2004 Chief, Division of Pediatric Gastroenterology and Nutrition, Johns
Hopkins University School of Medicine
2000 - Present Professor of Pediatrics
-3-
IV. LICENSURE AND CERTIFICATION
Licensure: Maryland, Missouri
Specialty Certification:
1973 National Board of Medical Examiners
1977 American Academy of Pediatrics #21135
2006 American Board Pediatric Transplant Hepatology Certifying Exam
Subspecialty Certification:
1991 Pediatric Gastroenterology and Nutrition
1997 Pediatric Gastroenterology and Nutrition
2004 Pediatric Gastroenterology and Nutrition
2006 Transplant Hepatology Boards
V. HONORS AND AWARDS
1963 The Virginia Judy Esterly Junior Scholar, Scripps College
1964 The Virginia Judy Esterly Senior Scholar, Scripps College
1975 Commencement Speaker, Scripps College
1976 Marquis Who's Who in American Women
1985 Pediatric Housestaff Faculty Recognition Award, St. Louis University
School of Medicine
1987 Society for Pediatric Research
1988-90 Johns Hopkins University Clinician Scientist Award
1991 Marquis Who's Who in the East
1993 The Best Doctors in America
1993 Member, American Board of Pediatrics, Subboard in Pediatric Gastroenterology
1994 National Institute of Health, Clinical Sciences Special Emphasis Panel Study Section
1995-96 Who's Who in North America
1996 National Institute of Health - Invited participant Viral Hepatitis Working
Group (NIDDK)
1996-99 Secretary/Treasurer and member, Executive Council, North American Society of
Pediatric Gastroenterology and Nutrition.
1997 Credentials Board for Pediatric Gastroenterology Training Program ACCME
1997-Present Children’s Liver Council of the American Liver Foundation
1998 The Alexander J. “Buck” Schaffer Award for Outstanding Clinical Teachers of
Pediatric House Officers
1998 - 2003 Secretary/Treasurer Childrens Digestive Health and Nutrition Foundation
1998 - 9 National Academy of Sciences, Institute of Medicine. Dietary Antioxidant Panel for
the Recommended Dietary Allowances.
1999 Top 25 Pediatricians in Baltimore
2000 -1 Guidelines for Children with Liver Disease - American Society of Enteral and
Parenteral Nutrition
2000 National Institutes of Health (NIAID) Reviewer for new initiative HCV
and Hemophilia
-4-
2001 - Present Johns Hopkins Pediatrics at Home Inc., Board of Trustees
2001 - Present Castle Connolly Top Doctors in America
2002 Co-Director - First Pediatric Hepatology Course for the AASLD (American
Association for the Study of Liver Diseases) Emory Conference Center,
Atlanta,GA
2002, 2004 NIDDK Special Emphasis Panel ZDKI-GRB8-JI (RO3 Grants Review)
2004-2005 Guide to America’s Top Physicians
2005 Visiting Professor, Scripps College Lois Langland Alumnae in Residence
2004-2005 Guide to America's Top Pediatricians
2005 NASPGHAN Distinguished Service Award “In Recognition and Appreciation
of Outstanding Contributions to Pediatric Gastroenterology”
2005 NIDDK Special Emphasis Panel ZDK1-GRB-CM1 Ancillary Studies - HCV
2005 FDA Antiviral Drug Products Advisory Committee
Special Emphasis Panel RFP NIH NIAID DMID 05-12 "Animal models
for the Prevention and Treatment of Hepatitis B and Hepatitis C"
2005 NIH ZAT1 SM (01) Clinical Trials of Silymarin for Liver Disease
2005 AASLD Nominating Committee
2006 Distinguished Alumna, Scripps College
2007 Invited Speaker – Viral Hepatitis – at the Festschrift for Eve Roberts, University of
Toronto
2007 NIDDK ZDK1GRB8J Study Section Review of T32 Training Grant in Pediatric
Gastroenterology
2007 NIH ZAT1 Complementary and Alternative Medicine Trials for 2007
Arnold Silverman Visiting Professorship, University of Colorado HCV
2007 Cambridge Who’s Who Among Executive and Professional Women “Honors Edition”
2008 Patient Safety Star Award - Johns Hopkins University School of Medicine
2008 International Who’s Who Historical Society
2008 Chairman ABP Gastroenterology Self Assessment Exam
2008 - present Johns Hopkins University Master Clinician
2008 NIDDK Hepatobiliary Pathophysiology Study section – Invited Participant
2008 NIH Digestive Sciences and Bioengineering Small Business Grant – Grant Review
Study Section Liver Transplantation and Viral Hepatitis
2008 NIH Digestive Sciences Small Business Grant Review
2008 NIH/NIDDK Drug-Induced Liver Failure Study Section
2008 - present Castle Connolly Top Doctors in America
2008 - 14 President-Elect, President, President Emeritus (2 years each) of the North American
Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)
2009 Recipient of the Johns Hopkins University Women’s Network Leadership Award
for the Medical School (East Baltimore Campus)
2010 Antiviral Drugs Advisory Committee (AVDAC) consultant
2010 -11 Marquis Who’s Who in America
2011 Best Doctors in America
2012 – 16 President, FISPGHAN (Federated International Societies of Pediatric
Gastroenterology, Hepatology, and Nutrition)
2012 Washington University School of Medicine, Distinguished Alumna Award
-5-
2013 NIDDK Special Emphasis Panel Limited Competition for the Continuation of the Drug
Induced Liver Injury Network Data Coordinating Center (DILIN DCC)
2013 Theodore Roosevelt High School, Distinguished Alumna Award
2013 Member of Board of Infectious Diseases in Children
2014 Castle Connolly Top Doctors in America
2014 AASLD Fellow
2014 Ad Hoc Reviewer VA Epidemiology Study Section
2015 Castle Connolly Top Doctors in America
VI. PROFESSIONAL AFFILIATIONS
MEMBERSHIP IN PROFESSIONAL ORGANIZATIONS:
1978-1997 American Academy of Pediatrics
1978-Present North American Society for Pediatric Gastroenterology
1979-1983 American Society for Enteral and Parenteral Nutrition
1979-1987 St. Louis Pediatric Society
1982-1994 American Institute of Nutrition
1982-1994 American Society of Clinical Nutrition
1985-Present American Association for the Study of Liver Diseases
1987-2006 Society for Pediatric Research
1988-2006 American Gastroenterology Association
VII. NATIONAL COMMITTEES
1989-1991 Chairman, By-Laws Committee and Council Member North American
Society of Pediatric Gastroenterology
1992 Member, Nominating Committee, AGA Section on Growth and
Nutrition
1995-1999 Member, Credentials Committee, ABP Subboard in Pediatric
Gastroenterology and Chairman 1998
1996 Member Schwachman Award Committee, North America
Society of Pediatric Gastroenterology and Nutrition
1996 - 1999 Secretary/Treasurer, North America Society of Pediatric Gastroenterology
and Nutrition
1997 Member, Training and Education Committee, American Association for
the Study of Liver Diseases
1997 Cystic Fibrosis Foundation Liver Disease Working Committee
-6-
2000 North American Society for Pediatric Gastroenterology and Nutrition -
Long Range Strategic Planning Committee
2001 - NASPGHN Hepatology Committee
2002 - Children's Liver Council/American Liver Foundation
2003 - 2004 NASPGHN Finance Committee
2003 - 2004 Chairman CDHNF Finance Committee
2003 - NASPGHN Nominating Committee
2004 - Scientific Advisory Board, Hepatitis Foundation International
2004 - Medical Second Opinions
2006 - AASLD Nominating Committee
2006 - NASPGHAN Awards Committee
2007 - Scientific Advisory Board
CDHNF
Campaign for Viral Hepatitis
AASLD Special Interest Group – Cholestatic Liver Disease
AASLD Special Interest Group – Pediatric Liver Disease
2008 - Chair Focused Study Group/Single Topic Conference
AASLD Pediatric SIG FSG/STC
2012-14 Chair, NASPGHAN Publications Committee
2013 FISPGHAN Expert Team on Viral Hepatitis
2013 Founding Member of the Board of Directors, Global Liver Institute
2012 – present NIDDK Hepatitis B Research Network: Chairman, Pediatric Committee,
Member Executive Committee, Ancillary Studies Committee, P and P
Committee
2006 – present NIDDK Children’s Liver Disease Research and Education Network: Chair,
Website and INH Committees, Member Biliary Atresia Clinical Trials
Committee
-7-
VIII. EDITORIAL APPOINTMENTS
Reviewer:
American Academy of Pediatrics Redbook 2013
American Journal Diseases of Children
American Journal of Gastroenterology
Archives Diseases of Children and Adolescents
Current Pediatric Reviews
Gastroenterology
Hepatology
Infectious Diseases in Children
Journal of Clinical Investigation
Journal of Pediatrics
Journal of Pediatric Gastroenterology and Nutrition
Laboratory Investigation
Medicine
Pediatric Infectious Disease
Pediatric Research
Journal of Pediatric Transplantation
American Journal of Respiratory and Critical Care Medicine
The Open Pediatric Medicine Journal
Hepatitis Scientific Advisory Board
Book Reviews: Schwarz KB, Biochemistry of the Essential Ultratrace Elements. Biochemistry
of the Elements, Volume 3 edited by Earl Frieden, Plenum Press, New York,
1984. Published in Quarterly Review of Biology, 1986.
Schwarz KB, Viral Hepatitis and Liver Disease, edited by Zuckerman. J Pediatr
Gastro and Nutr. (In press 1990).
Schwarz KB, Pediatric Gastroenterology and Nutrition. Edited by J.
Vanderhoof and W. Balistreri. Gastro (In Press 1991).
Karnsakul W, Schwarz KB. Hepatitis in Remington & Klein: Infectious
Disease of the Fetus and Newborn Child, 7th edition. Elsevier, (In Press)
2009.
Editorial board: Journal of Pediatric Gastroenterology and Nutrition (retired 2004)
Clinical Gastroenterology and Hepatology
Current Pediatric Reviews
Pediatric Infectious Disease Journal
-8-
IX. SELECTED INVITED LECTURES AND SYMPOSIA
1979 "Gastrointestinal Disorders in Children" Washington University School of
Medicine, Topic: "Fluid and Electrolyte Balance in Children with Ostomies"
1982 "Gastrointestinal Disorders in Children" Washington University School of
Medicine Keystone, CO
1982 "Emergency Care for Kids--Reye's Syndrome" Clinton County E.M.T.
Association, Breese, IL
1985 "Prolonged Elevation of Amino Transferases in Children with Unsuspected
Myopathy" Physician's Radio Network
1986 "Reye's Syndrome" Clinical Conference Speaker, St. Elizabeth's Hospital
Belleville, IL
1989 Moderator, Poster Symposia North American Society Pediatric
Gastroenterology and Nutrition, Chicago IL
1990 "Pediatric Liver Transplantation" Mercy Hospital, (Pediatric Ground Rounds),
Baltimore, MD
1990 "Viral Receptors", "Viral Hepatitis" Faculty member, Ross Symposium on
Pediatric Gastroenterology and Nutrition, Phoenix, AZ
1990 "Pediatric Liver Transplantation" (Hershey Medical Center, Pediatric Ground
Rounds), Hershey, PA
1991 "Update on Viral Hepatitis" Faculty member, University of Chicago Conference
on Pediatric Liver Disease, Chicago, IL
1991 "Hepatitis C" Topics in Gastroenterology (CME Course, JHMI)
1992 "Hepatitis B Vaccine" Peninsula General Hospital Pediatric Grand Rounds
1993 "Hepatitis B Virus: Bad News/Good News" Pediatric Grand Rounds, Johns
Hopkins Department of Pediatrics
1993 "Biliary Atresia: Ducts, Docs, and DNA" Grand Rounds, Division of Pediatric
Surgery, Johns Hopkins Hospital
1993 "Vitamin E" Minisymposium. FASEB, New Orleans, LA
1993 "Role of Viruses in Pediatric GI" Moderator, Trends, Baltimore, MD
-9-
1993 "Medical Management of Liver Failure" Johns Hopkins Update for Nurses,
Baltimore MD
1993 "Cystic Fibrosis Liver Disease" Symposium. CF Foundation, Dallas Texas
1994 "Consequences of Oxidative Stress: Clues to HBV Oncogenesis" Neurovirology
Seminar. Johns Hopkins University School of Medicine, Baltimore, MD
1994 "Hepatitis C" Pediatric Grand Rounds, St. Agnes Hospital, Baltimore, MD
1994 "Hepatitis C" Hemophilia Family Day, St. Agnes Hospital, Baltimore, MD
1994 "Vitamins" Moderator. Advances in Pediatric Nutrition (CME course) JHMI
1994 "Pediatric Gastroenterology Topics" Pediatrics for the Practitioner. JHMI
1995 α-Interferon Therapy of Hepatitis C in Hemophiliac Children. National
Hemophiliac Foundation, Atlanta, Ga.
1995 "Acute Liver Failure" Annual Ross Lecture. Pediatric Grand Rounds
University of Arkansas Department of Pediatrics
1995 "Update on Viral Hepatitis" Pediatric Grand Rounds. Fairfax Community
Hospital. Fairfax, Va.
1995 "Wilson's Disease, Johns Hopkins Hepatobiliary Course. Ocean City, MD.
1995 Antioxidant Effect of Vitamin A Supplementation in Premature Infants.
The Oxygen Society, Pasadena, CA
1996 ”Viral Hepatitis” Pediatric Grand Rounds. East Baltimore Medical
Center
1996 "Interferon for Hepatitis C" Annual Region III Hemophilia Treatment
Center Meeting. Bethesda, MD
1996 Hepatitis C Update. Saturday Pediatric Rounds. JHH
1996 Co-director - CME Course - JHU Hepatobiliary Update. Ocean City, MD
1996 “Gastro-esophageal Reflux” in Pediatrics for the Practitioner. Baltimore,
MD
1996 “Hepatitis C” Voice of America Radio Broadcast
-10-
1996 “Hepatitis C in Children” NIADDK - Viral Hepatitis Working Group
1996 “Hepatitis C: The Tip of The Iceberg” Pediatric Grand/Rounds. Johns
Hopkins
1997 “Oxidative Stress and HBV Hepatocarcinogenesis” - Adult
Gastroenterology Research Conference - Johns Hopkins University
1997 “Viral Hepatitis in Children” - Pediatric Grand Rounds
Franklin Square Hospital, Baltimore, Maryland
1997 “Vital Signs” ABC TV program on a Johns Hopkins pediatric liver
transplant patient
1997 “Interferon for Hepatitis C” - Region III Hemophilia Treatment Center
Annual Meeting - Wilmington, Delaware
1997 “Role of Oxidative DNA Damage in Hepatitis B Hepatocarcinogenesis” -
Adult GI Research Conference Johns Hopkins Medical Institutions
1997 “Update in Viral Hepatitis” - Franklin Square Hospital Pediatric Grand
Rounds
1997 “Update in Viral Hepatitis” - Johns Hopkins Transfusion Medicine Group
1997 “Hepatitis C in Hemophiliac Children” - National Hemophiliac Foundation
Region II Delaware
1997 “Management of Hepatitis C” - Topics in Gastroenterology, CME Course
Johns Hopkins Medical Institution
1997 “Hepatitis C in Hemophiliac Children” - National Hemophiliac Foundation
Region III New Jersey
1997 “Autoimmune hepatitis” NASPGN Annual meeting Toronto, Canada
1997 “Pediatric Liver Transplantation” - Pediatric Grand Rounds, Sacred Heart
Hospital, Cumberland, MD
1998 Update in Pediatric Hepatitis C Region II Hemophilia Treatment Center Annual
Meeting. Alexandria, VA.
1998 “Viral hepatitis” VCR and NBC television program for the American Liver
Foundation
-11-
1998 Role of Oxidative DNA Damage in Viral Hepatocarcinogenesis - USDA
Research Seminar
1998 “Neonatal Cholestasis” CD Rom for the Johns Hopkins Comprehensive
Transplant Center
1998 Pediatric G.I. Techniques in the Era of Cost Containment
Johns Hopkins Trends
1998 Liver/Small Bowel
Johns Hopkins Trends
1998 Challenges in Pediatric Transplantation
Johns Hopkins Trends
1998 Johns Hopkins Hepatobiliary Update
Ocean City, Maryland
1998 Transplant Lifestyles
Ocean City, Maryland
1999 Moderator - Treatment of Hepatitis B & C
AASLD Symposium AGA Annual Meeting - Orlando, Fl
1999 Immunopathogenesis of Hepatitis C in Children
Adult Gastroenterology Research Conference - Johns Hopkins
1999 Moderator - Symposium on Viral Infection in Hepatobiliary Disease
NASPGN Annual Meeting - Denver, Colorado
1999 Hepatitis C in Hemophiliac Children - National Hemophilia Foundation Annual
Meeting - Dallas, Texas
1999 Co-Director Symposium on Viral Infection of the Liver in Children
AASLD Annual Meeting - Dallas, Texas
1999 Meet-the-Professor Luncheon - Pediatric Viral Hepatitis
AASLD Annual Meeting - Dallas, Texas
2000 Chronic Liver Disease during Adolescents. Annual Meeting of the Society of
Adolescent Medicine - Arlington, VA.
2000 NIH Consensus Conference - Viral Hepatitis a-interferon Therapy of
Children with Hepatitis B
2000 Hepatitis C in Children - Mercy Medical Center - Baltimore, MD.
-12-
2000 Hepatitis C in Children -Meet-the-Professor - First World Congress of Pediatric
Gastroenterology, Hepatology and Nutrition, Boston, MA
2000 Moderator: Focused Study Group Alagille Syndrome: The Jagged Edge
AASLD Annual Meeting
2001 Ross Conference for Pediatric GI Fellows - What? When? Why? DRI's
Camelback, Arizona
2001 Anesthesia Grand Rounds: Neuropsychological Outcome of Children Post
Liver Transplantation
2001 GI Topics Course - Hepatitis B - Should it be treated?
2002 Pediatric Viral Hepatitis - HepDART Conference Northwestern University
CME Course, Maui, Hawaii
2001 Treatment of Viral Hepatitis in Children - Pediatric Grand Rounds, St. Agnes
Hospital, Baltimore, Maryland
2001 Pediatric Liver Transplantation - Sacred Heart Hospital, Cumberland, Maryland
2003 Johns Hopkins Comprehensive Transplant Center Video
2001 Invited Participant FDA Pediatric Advisory Subcommittee: Pediatric HCV Trials
2002 Co-Moderator: “Treatment of Viral Hepatitis in Children” 52nd
Annual Meeting –
AASLD - Dallas, Texas
2002 Pediatric Hepatitis C. Franklin Square Hospital Pediatric Grand Rounds,
Baltimore, Maryland
2004 Pediatric Liver Transplantation Video - Fujisawa Corporation
2002 Moderator Pediatric Gastroenterology Session - Annual Meeting of the Society
for Pediatric Research, Baltimore, Maryland
2002 Moderator - Food Allergy Planary Session- Annual Meeting North American
Society of Pediatric Gastroenterology, Hepatology and Nutrition, San Antonio,
Texas
2004 Invited Speaker: Chronic Hepatitis in Children - "Hepatitis C Virus" for the
AGA - Digestive Disease Week - May 18, 2004 New Orleans, Louisiana
2004 Meet the Professor - Treatment of HBV HCV and Career Development and
-13-
Mentoring - and Do We Need to Treat Hepatitis C? World Congress of
Pediatric Gastroenterology, Hepatology and Nutrition
2004 Meet the Professor - Viral Hepatitis and Pediatric Populations AASLD Annual
Meeting, Boston, Mass
2004 Early Morning Workshop - Treatment of Hepatitis C in Children - AASLD
Annual Meeting, Boston, Mass
2005 Lois Langland Alumna in Residence, Scripps College, Claremont, CA
2005 “31st Annual Topics in Gastroenterology and Liver Disease” Hepatitis Session
September 2005
2006 Invited Professor – Ross Conference for Advanced Fellows in Pediatric
Gastroenterology, Carefree, Arizona, 2006
2007 Invited Professor AASLD Annual Meeting Focused Study Group/Pegylated
Interferon + Ribavirin for Hepatitis C
2007 Pediatric HCV Roche Medical Affairs Research Summit, Chicago Ill.
2008 Invited Faculty Mt. Sinai School of Medicine Pediatric Liver Symposium -
“Viral Hepatitis in Children”
2008 Invited Faculty Pediatric Hepatitis B: Hepatitis B Foundation
2008 34th
Annual Topics in Hepatobiliary Disease: Inherited Liver Disease in Children
and Adults , Johns Hopkins
2008 Controversies in the Treatment of Viral Hepatitis NASPGHAN
Annual Meeting, San Diego, California
2008 Invited Presenter: “Impact of HBV in Women and Children”
House of Representatives Subcommittee Hearing, The Capital, Washington DC
2008 Invited Presenter: Maryland Viral Hepatitis Task Froce
2008 Moderator: Focused Study Group on Alagille’s Syndrome: The Cutting Edge
AASLD Annual Meeting. San Francisco, California
2011 Learning Luncheon HCV in children – NASPGHAN Annual Meeting, Orlando,
Fla Update on the Management of HBV and HCV in Children – Latin American
Society of Pediatric Gastroenterology – Santo Domingo, Dominican Republic
-14-
2012 Senior Faculty Ross Conference for Pediatric Gastroenterology Fellows,
Phoenix, Arizona – Negotiating a Contract
How Do We Treat Hepatitis C in Pediatrics? American Gastroenterology
Association Annual Meeting – San Diego, California
Cholestasis – Mexican Pediatric Society Annual Meeting, Mexico City, Mexico
Hepatitis B in Children – Pediatric Academic Societies – Boston, Mass
There’s a Liver Mass on Ultrasound – NASPGHAN Annual Postgraduate Course,
Salt Lake City, Utah
2013 Pediatric Liver Disease Awareness presentation at the Senate Office Building,
Washington, DC
Neonatal Cholestasis: An Emergency of a Different Kind. Pediatric Grand
Rounds, York Hospital, York, Pa
Metabolic Liver Disease in the Neonate; Metabolic Liver Disease in the Child;
Hepatic Malignancies - Kunwar Viren Oswal Course in Pediatric
Gastroenterology, Hepatology, Liver Transplantation and Nutrition – New Dehli,
India
2014 Pediatric Metabolic Liver Disorders; Diagnostic Challenges via Case CHOICE
Atlanta, GA
X. RESEARCH SUPPORT
1978 Washington University Clinical Research Center, Grant #44-00036, "Sodium
and Water Balance in the Infant with Ileostomy." P.I. (50% effort)
1979-1987 John F.J. Mackiewicz Memorial Fund-Cardinal Glennon Children's Hospital,
"Phosphorus Metabolism in Reye's Syndrome." P.I. ($30,000)
1980-1982 Mead Johnson Nutritional Division, "Acceptance, Tolerance and Growth of
Compromised and Potentially Compromised Infants for Whom Nutramigen is
Prescribed." P.I. ($10,000)
1981-1987 Peter Duvall Nutrition Research Fund, P.I. ($10,000)
1984-1987 National Institute of Health, R23 NS20835.02 "Lipid Peroxidation and
Antioxidants in Reye's Syndrome." P.I. ($107,500)
1988-1990 Johns Hopkins University Clinician Scientist Award, "Viral Hepatitis and
Iron-Induced Lipid Peroxidation." ($80,000)
-15-
1989-1990 National Reye's Syndrome Foundation, "Aspirin and Influenza B in Human
Hepatocytes." P.I. ($30,000)
1989-1990 Biological Science Research Grant, "Viral Hepatitis and Iron-Induced Lipid
Peroxidation." P.I.($7,500)
1991-1994 National Institute of Health R01HD28070-01 "Breath Ethane: Biomarker of
Vitamin A and E Deficiency" P.I. ($222,959)
1991-1992 Stetler Research Fund for Women Physicians "Role of Woodchuck Hepatitis
Virus in Promoting Oxidative DNA Damage in Primary Woodchuck
Hepatocytes" Sponsor for Dr. Molly O'Gorman. ($30,000)
1991-1992 Thomas Wilson Sanitarium Award "Breath Ethane: Biomarker of Vitamin A
and E Deficiency" P.I. ($10,000)
1993-1996 National Institute of Health Small Cancer R03CA59808-01A1 "Oxidative DNA
Damage and Hepatitis B Virus Oncogenesis" P.I. ($50,000)
1993-1995 Cystic Fibrosis Foundation Award "Breath Pentane and a Non-Invasive
Measure of Liver Function in Patients with Cystic Fibrosis" Sponsor for Dr.
Jeffrey Rosensweig. ($60,000)
1993 Biological Science Research Grant "Utility of Bile to Study Hepato Protective
Effects of Nutrient Antioxidants" (Technician salary) ($7,500)
1994 Cystic Fibrosis Foundation Student Research Award
"Transforming Growth Factor Beta as a Biomarker of Cystic Fibrosis Associated
Liver Disease", (Sponsor for Kathleen Page)($1,500)
1996 Cystic Fibrosis Foundation Clinical Research Grant Transforming Growth
Factor Beta in CF Liver Disease. $30,000
1997 The Thomas Wilson Sanitarium Foundation Grant
Hepatitis C in Baltimore City Children. $15,000.
1997-2000 National Institute of Health (Pediatric Hepatitis C)
Supplement to U19A140035 At the Southeastern Cooperative
Hepatitis C Research Group@. Co-Investigator $311,282
1997 National Hemophilia Foundation and Schering-Plough Corp. A Multi-center trial
of Intron A + Ribavirin for Treatment of Patients with Inherited Coagulation
Disorders and Chronic Hepatitis C@ - Co-investigator 1998 - 2000 -
$1000/patient
-16-
1999-02 “A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety
and Efficacy of 52 Weeks Lamivudine Treatment of a Dose of 3mg/kg in
Pediatric Subjects with chronic Hepatitis B”. Co-Investigator $157,615.
1999-01 Neuropsychological Outcome Following Pediatric Liver Transplantation
P.I. Kathleen B. Schwarz, M.D. $50,000
2000-03 Pegylated Interferon in Children with Chronic HCV: A Multi-Center
Trial. P.I. Kathleen B. Schwarz, M.D. Hoffman La Roche
06/01/00 - 06/01/03 $45,207
2000-03 IL-12 and IFN gamma Production in Children Receiving Pegylated Interferon
(PEG) Therapy for Chronic Hepatitis C (HCV)
06/01/00 - 06/01/03 Co-Investigator - Roche $180,000
2000 Immunodiagnostic use of a divalent peptide MHC-Ig Complex in patients
with rejection following orthotopic liver transplant (OLT) or with chronic
hepatitis C Virus (HCV) infection , Johns Hopkins Comprehensive Transplant
Center Pilot Project. P.I. Kathleen Schwarz, M.D.$20,000
2000-05 Subproject: Pediatric Acute Liver Failure - Lee W, PI. RO1 DK58369-01
9/01/00 - 8/31/05 $400/per patient
2000-04 NIH RO1 Viral Hepatitis in Children of Injection Drug Users RO1 DA13743-02
Schwarz KB. 10/01/00 - 9/30/04 $1,000,000
2002-05 An Extended Stratified Follow-Up Study in Pediatric Subjects with Chronic Hepatitis
B who have completed Previous Lamivudine Studies. GlaxoSmith Kline Schwarz
KB. 6/27/02-2/28/03 $55,678
2003-2009 Pegylated Interferon +/- Ribavirin for Children with Chronic HCV (Multi-
center Trial) – NIDDK – UO1DK067767 - $3.4M - 9/30/03 – 8/31/09
KB Schwarz PI (supplemental funding of $3.4M by Hoffman LaRoche ).
2002-2009 Novel Antigen and T&B Cell Response in Biliary Atresia. UO1DK62503 9/24/02-
5/31/09. $264,795/yr Cholestatic Liver Disease Consortium and Cystic Fibrosis
Liver Disease. $50k/y
2005 - 2010 Adefovir Dipivoxil for the Treatment of Children with Chronic Hepatitis B.
Sponsor Gilead. 3/05-2/10. $124,909 direct costs K. Schwarz, PI (for Hopkins)
2005 – 2010 A Multi-Center Group to Study Acute Liver Failure in Children. Squires R, PI,
Schwarz KB Co-Investigator NIDDK UO199-08-30-03, $12,500 9/1/05-8/31/10
2008 - 2015 Effect of HBV DNA Methylation and the Mutant 1762 T/ 1764A on Viral Load
& HCC Hepatitis B Clinical Research Network UO1 DK 082916-01 $1,872.615
-17-
Direct Costs K Schwarz PI for Hopkins.
2007 - 2011 Evaluation of PK Study, Safety, Tolerability and Efficacy of Entecavir (ETV) in
Pediatric Patients with Chronic Hepatitis B Infection who are HBeAG-Positive.
Bristol Meyer Squibb AI463-028-008. Schwarz, KB, PI . $73,366.00
2008 – 2009 Studies in Pediatric Liver Transplantation (SPLIT) Emmes 5 UO1 DK061693
Schwarz, KB, PI $1,125
2009 Johns Hopkins Urban Health Institute -Health Care Issues in Homeless Children
Schwarz, KB. PI $5,000
2009 – 2014 The Johns Hopkins Pediatric Liver Center ChiLDREN Grant - U01 DK062503-8
NIH/NIDDK Schwarz ,KB. PI $1,378,637
2010 – 2014 The Peds C LTFU Protocol No. NV17424 (Schwarz) Hoffman La Roche
Pegylated Interferon +/- Ribavirin for Children with Chronic HCV the NV17424
Schwarz,KB PI Direct $632,880 IDC $ 215,179
2007 – 2013 Pediatric Entecavir AI-463-028-008 (Schwarz)
BMS
Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir
(ETV)
To evaluate the pharmacokinetics, safety, tolerability and efficacy of Entecavir in
Pediatric subjects with Chronic Hepatitis B virus Infection who are HBeAg-Positive.
$73,366
2010 - 2015 AI-463-189-003 (Schwarz)
BMS
Comparative Study of the Antiviral Efficacy and Safety of Entecavir (ETV) Versus
Placebo in Pediatric Subjects with Chronic Hepatitis B Virus (HBV) Infection who are
HBeAg-Positive. $56,343
2012 – 2014 A Two-Part, Open –Label, Single-Arm Phase ½ Study of Safety, Pharmacokinetics,
and Efficacy of Telaprevir in Combination With Peginterferon and Ribavirin in
Pediatric Subjects Aged 3-17 Infected With Genotype 1 Hepatitis C Virus.
Vertex
Direct $33,287 IDC $11,317 Total: 44,604
2013 – 2014 Development and Implementation of a feeding protocol for neonates following bowel
resection to improve feeding tolerance and reduce liver injury. Darla Shores, MD,
Kathleen B. Schwarz, MD, Lynn Mattis, RN. Thomas Wilson Grant $18,000
2012 – 2015 A phase IIIb parallel croup, open label study of pegylated interferon ala-2a
monotherapy compared to intreated control in children with HBeAg positive chronic
hepatitis NB. Kathleen B. Schwarz, M.D.
-18-
Genenetech (Roche)
Direct $75,388 IDC: 25, 628 April 2012 – March 2015
2013 – 2015 Stefany Honigbaum, MD, Clinical Research Award from the American College of
Gastroenterology in the amount of $10,000 for your project entitled, "The role of
LOXL2 in fibrosing pediatric lung and liver disease.”
2014 – 2016 Emilia Shin, MD, NIH T32 Department of Pediatrics, “The Utility of Whole Genome
Sequencing to Identify Susceptibility Genes and Infectious Triggers of Autoimmune
Hepatitis”.
XI. MAJOR ACADEMIC SERVICE
St. Louis University School of Medicine 1978-1987:
1978-1987 Lecturer in clinical nutrition to freshman and junior medical students as
part of a grant given to Dr. Robert E. Olson by the National Fund for
Medical Education to develop an integrated program of basic and clinical
nutrition in the Medical curriculum.
1978-1981 Physician's Assistant Program - Lectures in Infant Nutrition and Pediatric
Gastroenterology
1979-1987 Nutrition Education Committee
1980-1981 Co-Chairman Gastrointestinal Diseases Module for Sophomore medical
students
1978-1987 Attending physician, Division of Pediatric Gastroenterology and Nutrition
Cardinal Glennon Children's Hospital 1978-1987:
1978-1984 Chairman, Nutritional Advisory Committee
1978-1987 Total Parenteral Nutrition Team
1978-1987 Reye's Syndrome Management Team
1978-1980 Child Abuse Management Team
1979-1987 Intensive Care Unit Committee
-19-
1980-1984 Chairman, Housestaff Evaluation Committee
Johns Hopkins University and Hospital (1987 - present):
1987-present Attending physician, Pediatric Gastroenterology and Nutrition - 3-4
months/year
1998-2007 Attending physician, General Pediatrics-1 month/year
1987-2007 Pediatric Nutritional Advisory Committee
1989-1992 Medical School Admissions Committee
1988-2000 Director, Pediatric Gastroenterology Fellowship Program - Division of
Pediatric Gastroenterology and Nutrition
1989-present Medical Director, Johns Hopkins Pediatric Liver Center
1991-1998 Pediatric Clinical Research Unit Advisory Committee
1991-1995 Johns Hopkins Hospital Patient Satisfaction Committee
1991-1995 Johns Hopkins Hospital Organ Donor Committee
1993-present Member, Liver and Gastrointestinal Disease Teaching Team Sophomore
Pathophysiology Course
1996-2004 Member Organ and Tissue Donor Council JHMI
1996-present Member Pediatric Surgery Advisory Board Johns Hopkins Hospital
1996-1997 Gastroenterology Search Committee JHMI
1997- 2001 Member, JHH Radiology Advisory Committee
1997 PCRU Director - Search Committee, Department of Pediatrics
Johns Hopkins Medical Institution
1999 - 2001 Co-Director for Research - Comprehensive Transplant Center
2000 - 2004 Member GOR Performance Improvement Committee
-20-
2001 - 2003 Clinical Data and Documentation Committee
2001 - 2002 Committee for the Women’s Leadership Council
2002 – Present Member, Johns Hopkins Pediatrics at Home Board of Trustees
2004 Department of Pediatrics Performance Improvement Committee
2004 - present 3 PPC Subcommittees
2008 Director: Medical Student Elective Health Care Issues
In Homeless Children
XII. PUBLICATIONS:
1. Oberholzer VG, Schwarz, KB, Smith CH, Dietzler D, and Hanna TL, Microscale
modifications of a cation-exchange column procedure for plasma ammonia. Clin Chem
1976;22(12)76-81.
2. Schwarz, KB, Keating JP, Ternberg JL, and Bell MJ, Sodium balance following Soave
ileo-endorectal pull-through. J Pediatr Surg 1977;12:945-953.
3. Keating JP, Schwarz, KB, and Ternberg JL, An experience with total parenteral nutrition
in children. Am J Clin Nutr 1977;30:1506.
4. Schwarz, KB, Keating JP, Ternberg JL, and Holtmann B, Congenital lip pits and
submucous cleft palate; report of a case with Hirschsprung's disease involving the entire
colon and terminal ilem. J Pediatr Surg 1979;14:162.
5. Schwarz, KB, Goldstein P, Witztum JL, and Schonfeld G, Fat-soluble vitamin
concentrations in hypercholesterolemic children treated with colestipol. Pediatrics
1980;65:243.
6. Schwarz, KB, Witztum J, Schonfeld G, Grundy SM, and Connor WE, Elevated
cholesterol and bile acid synthesis in a young patient with homozygous familial
hypercholesterolemia. J Clin Invest 1979;64:756-760.
7. Schwarz, KB, Karl IE, and Alpers DH, Effect of intralumenal cation exchange resin on
excretion of ammonia in rat ileum. Pediatr Res 1981;15:1473-1477.
8. Schwarz, KB, Peden VH, and Craddock T, Zinc deficiency in a premature infant with
severe short bowel syndrome. Nutr Reviews 1982;40:81.
-21-
9. Schwarz, KB, Wolverson J, DeMello DE, King J, Nolan B, and Lewis JE, Budd-Chiari
Syndrome in a child. J Pediatr Gastr and Nutr 1982;1:277.
10. Schwarz, KB, Ternberg JL, Bell MJ, and Keating JP, Sodium needs of infants and
children with ileostomy. J Pediatr 1983;102:509-513.
11. Gurevitz M, DeMello DE, Tombaugh GC and Schwarz, KB, Reye's Syndrome (RS)
simulation in rats with elemental phosphorus. J Natl Reye's Syndrome Foundation
1982;3:32.
12. Kotagal S, Rolfe U, Schwarz, KB and Escober W, "Locked-In" State Following Reye's
Syndrome. Ann of Neurol, 1984;15 (6):599-601.
13. Schwarz, KB, Gurevitz M, Kanjanajjulpan P, Ylagan M, Schonfeld G and Fitch CD,
Decreased plasma vitamin E suggests role for lipid peroxidation in Reye's Syndrome
(RS). J Nat'l Reye's Syndrome Foundation 1983;4:59.
14. Schwarz, KB, Burris GC, DeMello DE, Hyams JS, Biller JA, Miksamak MG, Winter,
H.S., and Grand, R.J., Prolonged elevation of amino transferases in children with
unsuspected myopathy. Am J Dis Child 1984;138:1121-1124.
15. Schwarz, KB, Zimmerman DC, Alpers DH and Avioli LH, Gender differences in antacid-
induced phosphate depletion in rats. Gastroenterology 1985;89:313-320.
16. Knutsen A, Shah M, Schwarz, KB and Tsai CC, Graft versus host-like illness in a child
with phenobarbital hypersensitivity. Pediatrics 1986; Oct;78(4):581-4.
17. Gurevitz M, Weber T, Danis R, Craddock T, Grosfeld J, Ternberg JL and Schwarz, KB,
Sodium homeostasis in infants with biliary drainage procedures. Am J Dis Child
1986;140:535?538.
18. Schwarz, KB, Arey BJ and Mahanty, S. Aspirin stimulates malondialdehyde production.
J. of Nat'l Reye's Syndrome Foundation 1987;7:30-33.
19. Schwarz, KB, Larroya S, Kohlman L and Morrison A. Erythrocyte lipid abnormalities in
Reye's Syndrome. Pediatr Res 1987;21(4):352-356.
20. Schwarz, KB, Larroya S, Arey B, Vogler C and Schulze I. Influenza B Virus has
antioxidant effect in mouse liver mitochondria. J. Nat'l Reye's Syndrome Foundation
1987;7:47.
21. Schwarz, KB, Larroya S, Kohlman L, and Morrison A. Erythrocyte lipid abnormalities
in Reye's Syndrome. Pediatr Res 1987;21:352.
-22-
22. Arens MA, Knutsen AP, Schwarz, KB, Roodman SR and Swierkosz EM, Multiple and
persistent viral infections in a patient with bare lymphocyte syndrome. J Infect Dis.
1987;156:837.
23. Mings R, Knutsen AP, Krantman H, Schwarz, KB and Roodman SR, Chronic diarrhea in
a 5 month-old infant. Ann Allergy 1987;58:322, 372-374.
24. Gurevitz M, Schulze IT, Arens MQ, Swierkosz EM and Schwarz, KB, Effect of
influenza B virus on nutrient transport in cultured epithelial cells. Lab Invest
1987;57:657-664.
25. Schwarz, KB, Arey BJ, Tolman K and Mahanty S. Iron chelation as a possible
mechanism for aspirin induced malondialdehyde production by mouse liver microsomes
and mitochondria. J Clin Invest 1988;81:165.
26. Sotelo-Avila C, Danis RK, Krafcik J, Malik M and Schwarz, KB. Cholecystitis in a 17
year-old boy with recurrent jaundice since childhood. J Pediatr 1988;112:668.
27. Shah MD and Schwarz, KB, Hazards of small amounts of heparin in a patient with
subclinical vitamin K deficiency J Parent and Ent Nutr 1989;13:324-325.
28. Malik M, Connors R, Schwarz, KB, and O'Dorisio TM. Hormone-producing
ganglioneuroblastoma simulating intestinal pseudo obstruction. J Pediatr
1990;116(3):406-408.
29. Malik M, Schwarz, KB, Kotagal S. Syringomyelia and syringobulbia presenting as
pseudostricture of the cervical esophagus. J Pediatr Gastr Nutr 1990;11:115-117.
30. Schwarz, KB, Moore TJ, Willoughby RE and Yolken RE. Growth of Group A
rotaviruses in a human liver cell line. Hepatology 1990;12;4:638-643.
31. Schwarz, KB, Larroya S, Vogler C, Sippel CJ, Homan S, Cockrell R and Schulze I. Role
of Influenza B virus in hepatic steatosis and mitochondrial abnormalities in a mouse
model of Reye Syndrome. Hepatology 1991;12(1):96-103.
32. McCloskey J, Schleien C, Schwarz, KB, Klein A and Colombani P. Severe hypoxemia
and intrapulmonary shunting reversed by liver transplantation in a pediatric patient. J
Pediat 1991;118(6):902-904.
33. Refat M, Moore TJ, Kazui, M, Risby TH, Perman, JA and Schwarz, KB. Utility of
breath ethane as a noninvasive biomarker of vitamin E status in children. Pediatr Res
1991;30(5):396-403.
34. Risby TH, Maley W, Scott RP, Bulkley GB, Kazui M, Sehnert S, Schwarz, KB et al.
Evidence for free radical-mediated lipid peroxidation at reperfusion of human orthotopic
liver transplants. Surgery 1994;115:94-101.
-23-
35. Bancroft JD, Bucuvalas JC, Ryckman FC, Dudgeon DL, Saunders RC and Schwarz, KB.
Antenatal diagnosis of choledochal cyst. J Pediatr Gastr Nutr 1994;18:142-145.
36. Oliva MA, Todo S, Perman JA, Saavedra JM, Young J, and Schwarz, KB. Successful
intestinal transplantation for microvillus inclusion disease. Gastroenterology 1994;
106:771-774.
37. Schwarz, KB, Moore TJ, Sharma S, Clements MG, Seligman P. Activated THP-1 cells
depress mitochondrial respiration in Hep G2 cells infected with influenza B virus. Mol
Cell Probe 1994;8:345-351.
38. Ramos-Soriano AG, Schwarz KB. Recent advances in the hepatitides. Gastroenterol
Clin North Am. 1964 Dec;23(4):753-67.
39. O’Gorman MA, Fivush BA, Colombani P, Burdick J, Schwarz, KB. Proximal renal
tubular acidosis secondary to FK506 in pediatric liver transplant patients. Clin
Transplant 1995;9(4):312-316.
40. Ramos AG, Mitchell SE, Fair JE, Colombani PM, Schwarz, KB. Severe gastrointestinal
bleeding following liver transplant in young children. J Pediatr Gastr Nutr
1996;22(4):389-94.
42. Schwarz, KB, Cox J, Sharma S, Witter F, Clement L, Sehnert S, and Risby TH. Cigarette
smoking is pro-oxidant in pregnant women regardless of antioxidant nutrient intake. J
Nutr Med 1995;5:225-234.
43. Schwarz KB. Viral infection and oxidative stress. A review. Free Radical Bio Med
1996;21:641-649.
44. Bollinger ME, Arrendondo-Vega FX, Santisteban I, Schwarz, KB, Hershfield MS,
Lederman HM. Neonatal giant cell hepatitis as a complication of adenosine deaminase
(ADA) deficiency. N Engl J Med (May 23),1996;334:1367-1371.
45. Colombani PM, Cigarroa FG, Schwarz KB, Maley WE, Klein AS. Liver
transplantation in infants younger than 1 year of age. Ann Surg 1996;223(6):658-62.
46. Schwarz KB, Cox JM, Sharma S, Clement L, Witter F, Abbey H, Sehnert S, and Risby
TH. Pro-oxidant effects of maternal cigarette smoking in formula-fed newborns. J
Pediatr Gastr Nutr, 1997;24(1):68-74.
47. McKee M, Mattei P, Schwarz KB, Wise B, and Colombani P. Steroid withdrawal in
Tacrolimus (FK506)-treated pediatric liver transplant recipients. J Pediatr Surg,
1997;32(7):973-975.
-24-
48. Yokois N, Perlman E, Colombani PM, and Schwarz KB. Kaposi sarcoma presenting as a
protracted multisystem illness in an adolescent liver transplant recipient. Liver Transplant
Surg 1997;3(5):1-5.
49. Bobo L, Ojeh C, Chiu D, Machado A, Colombani PM and Schwarz KB. Lack of
evidence for rotavirus by polymerase chain reaction/enzyme immuno assay of
hepatobiliary samples in children with biliary atresia. Pediatr Res1997;41(2):
229-34.
50. Novy M, Schwarz KB. Nutritional considerations and management of the child with
liver disease. Nutrition 1997;13(3):177-184.
51. Schwarz KB, Cox JM, Sharma S, Clement L, Humphrey J, Gleason C, Helen Abbey,
Sehnert SS and Risby TH. Antioxidant effect of Vitamin A supplementation in
premature infants. J Pediatr Gastro & Nutr 1997;25:408-414.
52. Shneider BL, Fox VL, Schwarz KB, Watson CL, Ananthanarayanan M, Thevananther S,
Christie DM, Hardikar W, Setchell KDR, Mieli-Vergani G, Suchy FJ, Mowat AP.
Hepatic Basolateral Sodium-Dependent Bile Acid Transporter Expression in Two
Unusual Cases of Hypercholanemia and in Extrahepatic Biliary Atresia. Hepatology
1997;25(5):1176-1183.
53. Rosensweig JN, Masako O, Page K, Potter CJ, Perlman E, Thorgeirsson S. And Schwarz,
KB. Transforming Growth Factor Beta in Children with Biliary Atresia and Cystic
Fibrosis Associated Liver Disease. Pediatric Res 1998;44(3):402-409.
54. Schwarz KB, Cox J, Sharma S, Risby TH, Ogburn PL, VanWinter J, Kanayama M, Bibus D,
and Holman RT. Deficiency of n3 and n6 fatty acids in pregnancy: time course and effect of
antioxidant nutrients. J Nutr Envir Med 1999;8:335-344.
55. Orentas RJ, Lemas MV, Mullin MJ, Colombani PM, Schwarz KB, Ambinder R. Feasibility of
cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using
haploidentical donors. J Hematotherapy 1998 7:257-261.
56. Leung W, Colombani P, Lau H, Schwarz KB, Wise B, and Friedman A. Long term complete
remission and immune tolerance after intensive chemotherapy for lymphoproliferative disorders
complicating liver transplant. Transplantation 1999;67(11):1487-9.
57. Choo-Kang LR, Benson J, Fry T, and Schwarz KB. Pneumatosis cystoides intestinalis
presenting with labial crepitus in an infant with acute lymphoblastic leukemia. J Ped Gastro
Nutr 1999;4:442-5.
58. Zellos A, Thomas D, Sharma S, Mocilnikar K, Stamato L, Perlman E, Boitnott J and Schwarz
KB. High viral load and mild liver injury in young hemophiliacs compared to other children
with hepatitis C virus (HCV) infection. J Pediatr Gastroenterol Nutr 1999;29:418-423.
-25-
59. Cohen M, Wise B, Stamato L, Colombani PM and Schwarz KB. Utility of liver biopsy culture
in pediatric liver transplant recipients. Pediatr Transplan. 1999 Nov;3(4): 322-7.
60. Praghakaran K, Wise B, Chen A, Schwarz K and Colombani P. Rational Management of
Posttransplant Lymphoproliferative Disorder in Pediatric Recipients. J Pediatric Surgery
Vol 34, No1 (January), 1999:pp112-116.
61. Colombani PM, Lau H, Prabhakaran K, Maley W, Wise B, Schwarz KB, and Klein A.
Cumulative experience with pediatric living related liver transplantation.
J Pediatr Surg 2000;35(01):9-12.
62. Schwarz KB, Zellos A. Efficacy of Octreotide in Children with Chronic Gastrointestinal
Bleeding. J Pediatric Gastroenterology and Nutrition. 30(4);April 2000;442-46.
63. Schwarz KB. Esophagocolonic fistula presenting as feculent emesis in a pediatric patient post
diaphragmatic hernia repair. Am Journal of Gastroenterology 08/2000 95(9):2561-2561.
64. Conner, KG, Schwarz KB. Guidelines for Children with Liver Disease - American
Society of Enteral and parenteral Nutrition JPEN Jan/Feb Supplement 2002 pg 202-
205.
65. Darbari A, Sabin KM, Shapiro CH, Schwarz KB. Epidemiology of Primary Hepatic
Malignancies in U.S. Children. HEPATOLOGY 2003 38(3);560-66.
66. O’Gorman MA, Sharma S, Groopman D, Tennart BC, Schwarz KB. Decreased oxidative DNA
damage and accelerated cell turnover in woodchuck hepatitis
Virus infected liver. Hepatology Research 2002;25(3);254-262.
67. Schwarz KB, Kew M, Klein A, Abrams R, Sitzmann J, Jones L, Sharma S, Britton R,
Di Bisceglie A and Groopman J. Increased hepatic oxidative DNA damage in patients with
hepatocellular carcinoma. Dig Dis Sci 2001 46(10):2173-2178.
68. Fan X, Solomon H, Schwarz KB, Kew MC, Ray RB and Di Bisceglie AM. Expression
of c-myc promoter binding protein (MBP-1), a novel eukaryotic repressor gene, in cirrhosis and
human hepatocellular carcinoma. Dig Dis Sci 46:(3)563 2001.
69. Jacobson K, Murray K, Zellos A and Schwarz KB. Meta-analysis of interferon monotherapy in
children with chronic hepatitis. J Pediatr Gastroenterol Nutr 2002;Jan;34(1):52-8.
70. Jonas MM. Kelley DA, Mizerski J, Badia IB, Areias JA, Schwarz KB, Little NR,
Greensmith MJ, Gardner SD, Bell MS, Sokal EM. Clinical trial of lamivudine in
Children with chronic hepatitis B. N Engl J. Med. 2002 May 30;346(22):1706-13.
71. Schwarz KB, Balisteri W. Viral Hepatitis. J Pediatr Gastroenterol Nutr. 2002;35 Suppl
1:S29-32.
-26-
72. Li, DY, Schwarz KB. Immunopathogenesis of chronic hepatitis C virus infection.
J Pediatr Gastroenterol Nutr. 2002;35(3):260-7.
73. Albayram F, Stone K, Nagey D, and Schwarz KB. Alagille Syndrome: Prenatal
Diagnosis and Pregnancy Outcome. Fetal Diagnosis and Therapy. Fetal Diagn Ther.
2002;17(3):182-4.
74. Oliva-Hemker M, Schwarz KB. Improving the status of clinical trials in pediatric
gastrointestinal diseases. J Pediatr Gastroenterol Nutr. 2002 Oct;35(4):468-9.
75. Alvarez F, Schwarz K. Immune diseases of the liver and biliary tract. J Pediatr
Gastroenterology Nutr. 2002:35 Suppl 1:S39-43.
76. Balistreri WF, Chang MH, Ciocca M. Schwarz K, Porta G. Acute and chronic hepatitis:
Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology
and Nutrition. J Pediatr Gastroenterol Nutr. 2002;35 Suppl 2:S62-73.
77. Schwarz KB, Rosensweig J, Sharma S, Jones L, Durant M, Potter C and Narkewicz MR.
Plasma markers of platelet activation in cystic fibrosis liver and lung disease.
J Pediatric Gastro Nutr. 2003 Aug;37(2):187-91.
78. DeRusso PA, Spevak MR, Schwarz KB. Fractures in Biliary Atresia Misinterpreted as Child
Abuse. Pediatrics 2003. Pediatrics 2003;112:185-8.
79. Li DY, Boitnott JB, Schwarz KB. Human herpes virus-6 (HHV-6): a cause for fulminant
hepatic failure or an “innocent bystander?”. J Pediatr Gastroenterol Nutr. 2003 Jul;37(1):95.
80. Schwarz KB. Pediatric Issues in new therapies for hepatitis B and C. Curr Gastroenterol Rep.
2003 June;5(3):233-9.
81. Li Ding You, Schwarz, KB. Enteritis necroticans with recurrent fistula caused by Clostridium
perfringens in a child with cyclic neutropenia. J Pediatr Gastroenterol Nutr. 2004-
Feb;38(2):213-5.
82. Li DY, Schwarz KB. Autoimmune hepatitis. Adolesc Med Clin. 2004 Feb;15(1):131-43, x.
83. Schwarz KB. Treatment of Pediatric HCV: at least two roads in the yellow woods.
Expert Viewpoint - Clinical Care Options for Hepatitis; www.clinicaloptions.com/hep.
In Press 2005
84. Molleston TP, Schwarz KB. Treating children with chronic hepatitis can be a challenge.
Infectious Diseases in Children; September 2004:68-69.
85. Oberto C, Schwarz KB , Zambidis E, Campbell AB, Paidas C, Lindyberg K, Oliva-Hemker, M.
Malignant mesothelioma mimicking inflammatory bowel disease. Dig Dis Sci 49:434-7;2004.
-27-
86. Schwarz KB, Garrett B, Barnes Y, Ashe SM, Turtle M, Lamoreus J, Bowser, YD, Bareta J,
Weinbaum C, Alter MJ. Hepatitis B Vaccination Rate of Homeless Children in Baltimore -
The Journal of Pediatric Gastroenterology and Nutrition. JPGN 41:225-229 - 2005
87. Klein WM, Molmenti EP, Colombani PM, Grover DS, Schwarz KB, Boitnott J and
Torbenson MS. Primary Liver Carcinoma in Children and Young Adults.
Am J Clin Pathol. 2005 Oct;124(4):512-8.
88. Shneider BL, Brown MB, Haber B, Sokol RJ, Whitington PF, Schwarz KB, Squires R, Bezerra
J, Shepherd R, Rosenthal P and Hoofnagle JH. A Multi-Center Study of Biliary Atresia
Outcome in the United States (1997-2000) Ms. No. 2005759R1 – The Journal of Pediatrics
148(4);467-474.e1(April 2006)
89. Byrnes AA, Li DY, Park K, Thompson D, Mocilnikar C, Mohan P, Molleston JP, Narkewicz
M, Zhou H, Wolf SF, Schwarz KB, Karp CL. Modulation of the IL-12/IFN-γ Axis by IFN-α
Therapy for Hepatitis C. J Leukocyte Biol. 2007 Mar;81(3);825-834. Epub 2006 Dec 15.
90. Sokal E, Kelly DA, Mizerski J, Badia IB, Areias JA, Schwarz KB, Vegnente A, Little NR,
Gardener SD and Jonas MM. Long Term Lamivudine Therapy for Children with HBeAg-
positive Chronic Hepatitis B. HEPATOLOGY 2006 Feb;43(2):225-32.
91. Squires RH, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, Dhawan A,
Rosenthal P, Rodriques-Baez N, Murray KF, Horslen S, Martin G, Lopez MJ, Soriano H,
McGuire BM, Jonas MM, Yazig N, Shepherd RW, Schwarz K, Lobritto S, Thomas DW, Lavine
JE, Karpen S, Ng, V, Kelly D, Simonds N, Lynan LS. Acute Liver Failure in Children: The
First 348 Patients in the Pediatric Acute Liver Failure Study Group – The Journal of Pediatrics
May 2006 652-658.e2
92. Hardikar W, Schwarz KB. Current Pediatric Reviews: Closing in on Biliary Atresia Current
Pediatric Reviews, ISSN: 1573-3963 - Vol 2, Number 4 , November 2006
93. Hardikar W, Schwarz KB. Treatment options for chronic hepatitis B and C infection in
children. Expert Rev Anti Infect Ther. 2006 Aug;4(4):583-91. Review
94. Schwarz KB, Mohan P, Narkewicz MR, Molleston JP, Nash SR, Hu S, Wang K, Gries JM.
Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40kd) in children with chronic
hepatitis C. J Pediatr Gastroenterol Nutr. 2006 Oct;43(4):499-505.
95. Schwarz KB, Garrett B, Hampsey J, Thompson D. High Prevalence of Overweight and
Obesity in Homeless Baltimore Children and their Caregivers: a Pilot Study. MedGenMed.
2007 Mar 7;9(1):48.
96. DeRusso PA Ye W, Shepherd R, Haber BA, Shneider BL, Whitington PF, Schwarz KB,
Bezerra JA, Rosenthal P, Karpen S, Squires RH, Magee JC, Robuck PR, Sokol RJ. A report
from the Biliary ATresia Research Consortium. A Longitudinal Study of Growth Failure and
Outcome with Biliary Atresia. Hepatology, 2007 Nov;46(5):1632-8.
-28-
97. Murray KF, Rodrique JR, Gonzales-Peralta RP, Shepherd J, Barton BA, Robuck PR, Schwarz
KB. Design of the PEDS-C Trial: Pegylated Interferon +/- Ribavirin for Children with Chronic
Hepatitis C Viral Infection. Clin Trials. 2007;4(6):661-73.
98. Jonas MM, Little NR, Gardner SD, Schwarz KB. Long-term lamivudine treatment of children
with chronic hepatitis B: durability of therapeutic responses and safety. J Viral Hepat 2007:
Online Early Publication. doi:10.1111/j.365-2893.007.00891.x. J Viral Hepat 2007;15(1):20-7.
99. Schwarz KB, Garrett B, Bowser Y, Alter MJ, Thompson D and Strathdee S. Seroprevalence of
Hepatitis C Virus in Homeless Baltimore Caregivers and their Children. Journal of Health
Care for the Poor and Underserved 19 (2008):580-587.
100. Schwarz KB, Zellos A, Stamato L, Thomas DL, Boitnot J, Perlman E, Chong S. Percutaneous
Liver Biopsy in Hemophiliac Children with Chronic Hepatitis C Virus Infection. J Pediatr
Gastroenterol Nutr. 2008 Apr;46(4):423-8.
101. Gonzales-Peralta R, Schwarz KB. Hepatocellular Carcinoma in Two Young Adoescents with
Chronic Hepatitis C. J Pediatr Gastroenterol Nutr. 2009 May;48(5):630-5.
102. Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, Jonas MM,
Mohan P, Molleston JP, Murrary KD, Narkewicz MR, Rosenthal P, Smith LJ, Robuck PR,
Schwarz KB. Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds C
Trial. Hepatology, 2008 Mar;47(3):836-43.
103. Schwarz KB, Garrett B, Lee J, Thompson D, Thiel T, Alter MJ, Strathdee S. Positive Impact of
a Shelter-based Hepatitis B Vaccine Program in Homeless Baltimore and Adolescents. Journal
of Urban Health: Bulletin of the New York Academy of Medicine, 2008. 85(2)doi:10.
1007/s11524-008-9253-3.
104. Rodrique JR, Balistreri W. Haber B, Jonas M, Mohan P, Molleston JP, Murray KF, Markewicz
MR, Rosenthal P, Smith LJ, Schwarz KB. Impact of Hepatitis C Virus (HCV) Infection in
Children: Quality of Life, Emotional, and Cognitive Outcomes. J Pediatr Gastroenterol Nutr.
2009 Mar;48(3):341-7. doi: 10.1097/MPG.0b013e318185998f
105. Kamath BM, Schwarz KB, Hadzic N. Alagille Syndrome and Liver Transplantation.
J Pediatric Gastroenterol Nutr 2010 Jan 50(1):11-5.
106. Fortunato JE, Schwarz KB. Outcome after Percutaneous Endoscopic Gastrostomy in Children
and Young Adults. J Pediatr Gastroenterol Nutr. 2010 Apr;50(4):390-3. doi:
10.1097/MPG.0b013e3181aed6f1
107. Karnsakul W, Schwarz KB, Alford MK. “Managing pediatric hepatitis C: current and emerging
treatment options”. Ther Clin Risk Manag. 2009 Jun;5(3):651-60.
108. Haber B, Block J, Jonas M, Karpen S, London W, McMahon B, Murray K, Narkewicz M,
-29-
Rosenthal P, Schwarz KB. Recommendations for Screening, Monitoring and Referral of
Children with Chronic Hepatitis B in North America: Report of a Workshop. Pediatrics 2009
Nov;124(5):e1007-13. Epub 2009 Oct 5.
109. Foerster BR, Conklin LS, Petrou M, Barker PB, Schwarz KB. Minimal hepatic
encephalopathy in children: evaluation with proton MR spectroscopy. AJNR Am J
Neuroradiol. 2009 Sept:30(8):1610-3. Epub 2009 Jun 9.
110. Zellos A, Roy A, Schwarz KB. Use of oral naltrexone for severe pruritus due to cholestatic
liver disease in children. Journal of Pediatr Gastro Nutr 2010 Dec;51(6):787-9.
111. Zellos A, Schwarz KB. New-onset autoimmune hepatitis in young patients with preexisting
liver disease: A mere coincidence? Dig Liver Dis. 2010 Sept;42(9):657-60.
112. Jonas MM, Block JM, Haber BA, Karpen SJ, London WT, Murray KF, Narkewicz MR,
Rosenthal P, Schwarz KB, McMahon BJ; Hepatitis B Foundation. Treatment of Children
with chronic Hepatitis B virus infection in the United States: patient selection and therapeutic
options. Hepatology. 2010 Dec;52(6):2192-205.
113. Rabizadeh S, Schwarz KB. Bacterial Infections in Solid Organ Transplants Recipients.
e Transplant Infectious Diseases January 2010.
114. Schwarz KB, Gonzalez-Peralta RP, Murray KF, Molleston JP, Haber BA, Jonas MM, Rosenthal
P, Mohan P, Balistreri WF, Narkewicz MR, Smith L, Lobritta SJ, Rossi S, Valsamakis A,
Goodman Z, Robuck PR, Barton BA, Peds-C Clinical Research Network. The combination of
ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents
with chronic hepatitis C. Gastroenterololgy 2011 Feb; 140(2);450-458 e1. Epub 2010 Oct 28.
115. Narkewicz MR, Rosenthal P, Schwarz KB, Drack A, Margolis t, Repka MX; PEDS-C Study
Group. J Pediatr Gastroenterol Nutr. 2010 Aug;51(2):183-6.
116. Schwarz KB. Hepatitis C: not so indolent in survivors of pediatric cancer? Pediatr Blood
Cancer. 2010 Jul 15;55(1):7.
117. Alonso EM, Limbers CA, Neighbors K, Martz K, Bucuvalas JC, Webb T, Murray KF,
Narkewicz MR, Rosenthal P, Schwarz KB. Cross-sectional analysis of health-related quality of
life in pediatric liver transplant recipients. Studies of Pediatric Liver Transplantation (SPLIT)
Functional Outcomes Group (FOG). J Pediatr. 2010 Feb;156(2):270-6.
118. Limbers CA, Neighbors K, Martz K, Bucucalas JC, Schwarz KB, Webb T, Varni JW, Alonso
EM; Studies of Pediatric Liver Transplantation Functional Outcomes Group. Health-related
quality of life in pediatric liver transplant recipients compared with other chronic disease
groups. Pediatr Transplant. 2011 May;15(3):245-53.
-30-
119. Ling SC, McKiernan PJ, Walters T, Schwarz KB, Garcia-Tsai G, Shneider B. Primary
prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future
research. J Pediatr Gastroenterol Nutr. 2011 Mar;52(3):254-61.
120. Rodrigue JR, Haber B, Jonas MM, Molleston JP, Murray KF, Narkewicz MR, Roesnthal P,
Smith LJ, Schwarz KB, Robuck PR, Barton B, Gonzales-Peralta RP. Peginterferon with or
without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive
outcomes in children. Hepatology 2011 May;53(5):1468-75.
121. Omenetti A, Bass LM, Anders RA, Clemente MG, Francis H, Guy CD, McCall S, Choi SS,
Alpini G, Schwarz KB, Diehl AM, Whitington PF. Hedgehog Activity, Epithelial-
Mesenchymal Transitions, and Biliary Dysmorphogenesis in Biliary Atresia. Hepatology
2011 Apr;53(4):1246-1258.
122. Schwarz KB. “More Lessons from the Taiwanese HBV Vaccine Program” Journal of
Infectious Diseases January 19, 2012; doi:10.1093.
123. Roy A, Wang C, Li C, Lu L, Hagedorn C, Schwarz KB. Phenotypic and Genotypic Differences
between a child with vertically acquired severe hepatitis C liver disease and his mother. J
Pediatr Gastroenterol Nutr. 2012 Apr;54(4):567-9.
124. Hourigan SK, Anders RA, Mitchell SE, Schwarz KB, Lau H. Karnsakul W .Chronic diarrhea,
ascites, and protein-losing enteropathy in an infant with hepatic venous outflow obstruction
after liver transplantation. Pediatr Transplant. 2012 Apr 10.doi: 10.1111j.1399-
3046.2012.01686.x [Epub ahead of print]
125. Lucas J, Thompson JW, Dubois L, McCarthy J, Tillman H, Thompson A, Shire N, Hendrickson
R, Diegues F, Goldman P, Schwarz KB, Patel K, McHutchinson J, Moseley MA. Metaprotein
expression modeling for label-free quantitative proteomics BNC Bioinformatics 2012, 13:74.
126. Imteyaz H, Karnsakul W, Levine MA, Burrows PE, Benson J, Hsu S, Schwarz KB. Unusual
case of hypothyroidism in an infant with hepatic hemangioma. J Pediatr Gastroenterol Nutr.
2012 May;54(5):692-5.
127. Mack CL, Gonzalez-Peralta RP, Gupta N, Leung D, Rosenthal P, Narkewicz MR, Roberts EA,
Schwarz KB. North American Society for Pediatric Gastroenterology, Hepatology and
Nutrition Practice Guidelines: Diagnosis and Management of Hepatitis C Infection in Infants,
Children and Adoloescents”. J Pediatr Gastroenterol Nutr. 2012 Jun;54(6):838-55.
128. Jonas M, Balistreri W, Gonzalez-Peralta RP, Haber B, Lobritto S, Mohan P, Molleston JP,
Murray KF, Narkewicz MR, Rosenthal P, Schwarz KB, Barton BA, Shepherd JA, Mitchell PD,
Duggan C. Peginterferon for Chronic Hepatitis C in Children Affects Growth and Body
Composition: Results from the Pediatric Study of Hepatitis C (PEDS-C) Trial. Hepatology.
2012 Aug;56(2):523-31.
-31-
129. Karnsakul W, Intihar K, Roy A, Colombani P, Schwarz KB. Living donor liver transplantation
in children: A single North American center experience over two decades. Pediatr Transplant.
2012 Aug;16(5):486-95. doi: 10.1111/j.1399-3046.2012.01725.
130. Squires R, Schwarz KB, Alonso E, Narkewicz M, Rodriquez-Baez N, Karpen S, Bucuvalas J,
Lobritto S, Rand ZL, Rosenthal P, Horslen S, Subbarou G, Kerkar N, Rudnick D, Romero, R,
Elifson S, Doo E, Lawlor S, Belle S. Intravenous N-acetylcysteine in Pediatric Patients with
Non-Acetaminophen Acute Liver Failure: A Placebo-Controlled Clinical Trial. Hepatology
In Press 2012 Aug 10. Doi:10.1002/hep. 26001 [Epub ahead of print]
131. Shneider B, Magee J, Karpen S, Rosenthal P, Schwarz KB, Kernar N, et al. “Cross-sectional
Multi-center Analysis of Portal Hypertension in 163 Children and Young adults with Biliary
Atresia”. J Pediatr Gastroenterol Nutr. 2012 Nov;55(5):567-73. doi:
10.1097/MPG.0b013e31826eb0cf.
132. Wolfe J, Anders R, Reddoch S, Schwarz KB, Savage W. Longitudinal Changes in Liver
Fibrosis in Children with Sickle Cell Disease Undergoing Chronic Transfusion Therapy. Acta
Gastroenterol Belg. 2012 Dec;75(4):419-24 .
133. Mogul D, Schwarz KB. Managing Children Infected with Hepatitis C Virus. Clinical Liver
Disease In press 2012.
134. Bennett J, Swanson PD, Hahn S, Schwarz KB. An exceptional family with three consecutive
generations affected by Wilson Disease. JIMD Rep. 2013;10:1-4. doi: 10.1007/8904_2012_206.
Epub 2013 Feb 7.
135. Molleston JP, Mellman W, Narkewicz MR, Balistreri WF, Gonzales-Peralta RP, Jonas MM,
Schwarz KB, et al. Assessment of Auto-antibodies and Their Relationship to Autoimmune
Disease during Treatment for Hepatitis C in Children. J Pediatr Gastroenterol Nutr. 2013
Mar;56(3):304-10. doi: 10.1097/MPG.0b013e3182774cae.
136. Roy A, Lieb W, Garrett B, Hodik M, Klipsch A, Young M, Barton B, Schwarz KB.
Recruitment and retention strategies in a clinical trial for children with chronic hepatitis C
infection. J Pediatr Nurs. 2013 May-Jun;28(3):243-8. doi: 10.1016/j.pedn.2012.08.006. Epub
2012 Sep 18.
137. Schwarz KB, Haber BH, Rosenthal P, Mack CL, Moore J, Bove K, Bezerra JA, Karpen SJ,
Kerkar N, Shneider BL, Turmelle YP, Whitington PF, Molleston JP,Murray KF, Ng VL,
Romero R, Wang KS, Sokol RJ, Magee JC; Childhood Liver Disease Research and Education
Network. Extra-hepatic anomalies in infants with biliary atresia: results of a large prospective
North American multi-center study. Hepatology 2013 Nov;58(5):1724-31.
138. Abbas MI, Oliva-Hemker M, Choi J, Lustik M, Gilger MA, Noel RA, Schwarz KB, Nylund
CM. Magnet Ingestions In Children Presenting to US Emergency Departments, 2002-2011.
JPGN 2013257(1)8-22.
-32-
139. Mohan P, Barton BA, Narkiewicz M, Molleston JP, Gonzalez-Peralta RP, Rosenthal P, Murray
KF, Haber B, Schwarz KB, Goodman ZD. Evaluating progression of liver disease from repeat
liver biopsies in children with chronic hepatitis C – a retrospective study. Hepatology 2013
Nov;58(5):1580-6.
140. Gurda GT, Zhu Q, Bai H, Devadason A, Pan D, Schwarz KB, Anders RA. The utility of Yes-
associated protein (YAP) expression in the diagnosis of persistent neonatal cholestatic liver
disease. Hum Pathol. 2014 May;45(5):1057-64.
141. Lin HC. Alvarez L, Laroche G, Melin-Aldana H, Pfeifer K, Schwarz KB, Whitington P,
Alonso EM, and Ekong UD. Rituximab as Therapy for Recurrence of Bile Salt Export Pump
Deficiency after Liver Transplantation. Liver Transplantation In press 2013.
142. Leonis MA, Alonso EM, Im K, Belle SH, Schwarz KB, Squires RH; Pediatric Acute Liver
Failure Study Group. Chronic acetaminophen exposure in pediatric acute liver failure.
Pediatrics. 2013 Mar;131(3):e740-6.
143. Roy A, Lieb W, Garrett B, Hodik M, Klipsch A, Young M, Barton B, Schwarz KB.
Recruitment and retention strategies in a clinical trial for children with chronic hepatitis C
infection. J Pediatr Nurs. 2013 May-Jun;28(3):243-8.
144. Alonzo EM, Martz K, Wang D, Yi MS, Neighbors K, Varni JW, Bucuvaloas JC; Schwarz KB.
Studies of Pediatric Liver Transplantation (SPLIT) Functional Outcomes Group (FOG). Pediatr
Transplant. 2013 Nov;17(7):605-11.
145. Gregorz G, Schwarz KB, Zhu Q, Bai H, Pan D, Anders, R, Devadason, A. Expression of the
Yes-associated protein (YAP) in persistent neonatal cholestatic liver disease. Human Pathology
2014 In press.
146. Sue PK, Pisanic N, Heaney C, Nelson K, Schwarz KB, Forman, M, Valsamakis A, Karnsakul
W. Variability of Hepatitis E serologic assays in a 4 year old liver transplant recipient:
Challenges to diagnosing Hepatitis E Virus infection in the United States. 2014
147. Schwarz KB , Molleston JP, Jonas MM, Wen J , Murray KF, Rosenthal P, Gonzalez-Peralta, R,
Lobritto S, Mogul D, Hooper G, Warne C, and Thompson B. Long-Term Growth Outcomes in
Children Treated for Chronic Hepatitis C in the PEDS-C Trial. In Press J Pediatrics 2014.
148. Bezerra JA, Spino C, Magee JC, Shneider BL, Roenthal P, Wang KS, Erlichman J, Haber B,
Hertel PM, Karpen SJ, Kerkar N, Loomes KM, Molleston JP, Romero R, Schwarz KB, et al.
Childhood Liver Disease Research and Education Network (ChiLDREN). Use of
corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia:
the START randomized clinical trial. JAMA. 2014 7;311(17):1750-9.
149. Koeck E, Mohan P, Iordanskaia T, Rossi C, Schwarz KB. Integrin Beta-8, but not Beta-5 or -6,
Protein Expression is Increased in Livers of Children with Biliary Atresia. JPGN Submitted
2014.
-33-
150. Iordanskaia T, Hubal MJ, Koeck E, Rossi C, Schwarz K, Nadler EP. Dysregulation of upstream
and downstream transforming growth factor-β transcripts in livers of children with biliary
atresia and fibrogenic gene signatures. J Pediatr Surg. 2013 Oct;48(10):2047-53.
151. Nadler E, Iordanskaia T, Rossi C, Mohan P, Anders R, Schwarz, KB. JPGN-14-365R1:
“Integrin Beta A-8, but not Beta A-5 or -6, Protein Expression is increased in livers of children
with Biliary Atresia”. JPGN 2014 Dec;59(6):679-83.
152. Shores DR, Bullard JE, Aucott SW, Stewart FD, Haney C, Nonyane BAS, Schwarz KB.
Incidence of Parenteral Nutrition-Associated Liver Disease and Enteral Feeding Practices
Among Infants with Bowel Resection. ICAN In Press 2014.
153. Ng VL, Haber BH, Magee JC, Miethke A, Murray KF, Michail S, Karpen SJ, Kerkar N,
Molleston JP, Romero R, Rosenthal P, Schwarz KB, Shneider BL, Turmelle YP, Alonso EM,
Sherker AH, Sokol RJ; Childhood Liver Disease Research and Education Network
(CHiLDREN. Medical status of 219 children with biliary atresia surviving long-term with their
native livers: results from a North American multicenter consortium. J Pediatr. 2014
Sep;165(3):539-546.e2. doi: 10.1016/j.jpeds.2014.05.038. Epub 2014 Jul 9.PMID:25015575.
154. Schwarz KB, Olio DD, Lobritto SJ, Lopez MJ, Rodriguez-Baez N, Yazigi NA, Belle SH, Zhang
S, Squires RH; for the Pediatric Acute Liver Failure Study Group (PALFSG). An Analysis of
Viral Testing in non-Acetaminophen (non-APAP) Pediatric Acute Liver Failure (PALF). J
Pediatr Gastroenterol Nutr. 2014 Jul 24. [Epub ahead of print]PMID:25079486.
155. Clemente MG, Patton JT, Yolken R, Whitington PF, Parashar UD, Jiang B, Raghunathan TR,
Schwarz KB, and the Childhood Liver Disease Research and Education Network. Prevalence
of Groups A and C Rotavirus Antibodies in Infants with Biliary Atresia and Cholestatic
Controls. Submitted J Pediatr 2014.
156. Jonas MM, Schwarz KB, Gonzalez-Peralta R, Lobritto S, Molleston JP, Murray KF, Rosenthal
P, Wen J, Wat C, Pavlovic V and Warne C. Long-Term Growth Outcomes in Children Treated
for Chronic Hepatitis C. J Pediatr 2014.
157. Karnsakul W, Schwarz KB. Hepatitis in Remington & Klein: Infectious Disease of the Fetus
and Newborn Child, 8th edition. Elsevier, 2014 (in press).
158. Karnsakul W, Schwarz KB. Autoimmune hepatitis in: McMillan, Barrett, Boney, and Jones
(ed.) Clinical Decision Support digital program on Pediatrics, first edition, 2014.
159. Karnsakul W, Schwarz KB. Viral hepatitis in: McMillan, Barrett, Boney, and Jones (ed.)
Clinical Decision Support digital program on Pediatrics, first edition, 2014
-34-
160. Sue PK, Pisanic N, Heaney CD, Mixson-Hayden T, Kamili S, Nelson K, Schwarz KB, Forman
M, Valsamakis A, Karnsakul W, Ticehurst J. Variability of hepatitis E serologic assays in a
pediatric liver transplant recipient: challenges to diagnosing hepatitis E virus infection in the
United States. Transpl Infect Dis. 2015 Feb 4 doi: 10.1111/tid.12366. [Epub ahead of print]
PMID: 25648626 [PubMed – as supplied by publisher]
XIII. BOOK CHAPTERS (AND NON-REFERRED PUBLICATIONS)
1. Schwarz, KB and Olson RE. Ch. 49. Requirements and Absorption of Fat-Soluble Vitamins
During Infancy in Lebenthal, E. (ed.). Textbook of Gastroenterology and Nutrition in Infancy
Vol 2. Raven Press, New York, 1981.
2. Schwarz, KB, Vitamins in Modern Day Society (Chapter) in Walker WA and Watkins J,
(editors), Nutrition in Pediatrics ? Basic Sciences and Clinical Applications. Little, Brown and
Company, Boston, Massachusetts 1985.
3. Schwarz, KB, Requirements and Absorption of the Fat Soluble Vitamins During Infancy in
Lebenthal, E. (Ed) Textbook of Gastroenterology and Nutrition in Infancy. Raven Press, New
York 1989.
4. Schwarz, KB, The Child With Abdominal Pain: Psyche or Soma? Practical Gastroenterology,
1989, 13(8):65-73.
5. Perman JA and Schwarz, KB. Hepatitis, in Primary Pediatric Care eds. Hockelman, Friedman,
Nelson, and Seidel. Mosby Year Book, Baltimore, MD 1992.
6. Ramos A and Schwarz, KB. Recent Advances in the Hepatitides. Gastroenterology Clinics of
North America 1994. Pediatric Gastroenterology, Part I, 1994; 23:753-768.
7. Perman JA and Schwarz, KB. Hepatitis - in Hoeklman et al. Primary Pediatric Care 1994,
Mosby Year Book Inc. Baltim5. Perman JA and Schwarz, KB. Hepatitis, in Primary
Pediatric Care eds. Hockelman, Friedman, Nelson, and Seidel. Mosby Year Book, Baltimore,
MD 1992.
6. Ramos A and Schwarz, KB. Recent Advances in the Hepatitides. Gastroenterology Clinics of
North America 1994. Pediatric Gastroenterology, Part I, 1994; 23:753-768.
7. Perman JA and Schwarz, KB. Hepatitis - in Hoeklman et al. Primary Pediatric Care
1994, Mosby Year Book Inc. ore, MD 1994.
-35-
8. Ciguerroa, Schwarz, KB, and Colombani PM. Biliary Atresia. Surgery of Infants in
Children: Scientific Principles and Practice. Published by JB Lippincott Co. (in press
1994)
9. Schwarz KB. Vitamins (Chapter) edited by Walker WA and Watkins J. Nutrition in
Pediatrics - Basic Sciences and Clinical Applications. Publisher B.C. Decker Inc.
Hamilton.London 1996;8:115-135.
10. Perman JA and Schwarz, KB. Hepatitis in Primary Pediatric Care eds. Hockelman,
Friedman, Nelson, and Seidel. Mosby Year Book, Baltimore, MD 1997.
11. Zellos A and Schwarz KB. Congenital and Structural Abnormalities of the Liver In: D.A.
Kelly, editor. Diseases of the Liver and the Biliary System in Children. Oxford, U.K:
Blackwell Science 1999: 124-140.
12. Zellos A and Schwarz KB. Hepatitis C in Children, Contemporary Pediatrics 1998;15(4):
39-58.
13. Sokol RJ and Schwarz KB. Recommendations for Management of Liver and Biliary
Diseases in Cystic Fibrosis. J Pediatr Gastroenterol Nutr 1999;28 (Suppl. 1):S1-S13.
14. Schwarz KB. Nutritional Issues for Patients with Cholestatic Liver Disease. Nutrition
and the MD. In press 2000.
15. Schwarz, KB. Portal hypertension in Howard, Stringer, & Colombani eds: Surgery of the
Liver, bile- ducts and pancreas in children. Second edition Arnold (Publishers Limited)
London, England. In Press 2001
16. Schwarz KB, Rigby, S . Nutrition Prevention and Treatment of Disease: Nutrition and
Liver Disease . Academic Press, Inc. In Press 2001
17. Schwarz, KB. Review: Pediatric Issues In New Therapies for Hepatitis B and C.
Current Gastroenterology Reports 2003, 5(3):233-9.
18. Li DY, Schwarz KB: Congenital and structural abnormalities of the liver. In: Kelly
D (eds), Disease of the Liver and Biliary system in Childhood, 2nd
edition, pp 162-182
2003, Blackwell Publishing.
19. LI, DY, Schwarz KB. Autoimmune Hepatitis in Adolescent Medicine Clinics -
Gastrointestinal Disorders in Adolescents - edit by J.S. Hyams 15(1): 131-43, 2004.
20. Schwarz KB. Viral Hepatitis in Children. In Advanced Therapy in Gastroenterology
and Liver Disease. 5th Edition Eds Theodore Bayless and Anna Mae Diehl
108:625-628:2005; B.C. Decker, Inc.
21. Cabellero B. ed. Encyclopedia of Human Nutrition 2e Ch 180: Hampsey J and Schwarz
-36-
KB. Liver disorders: Nutritional Management in press 2005. Encyclopedia of Human
Nutrition, Second Edition, Editors: B Caballero, L Allen and A Prentice. 2005
Elsevier Ltd. ISBN (Set): 0-12-150110-8
22. Hardikar W, Schwarz KB. Hepatitis Chapter 216, in: McInerny TK, Adam HM,
Campbell D, Kamat DK, Kelleher KJ, eds. Pediatric Primary Care 5th
Ed. Elk Grove
Village, IL: American Academy of Pediatrics; In press.2006
23. Sullivan S, Schwarz KB. Water-Soluble Vitamins. Chapter for the 6th
Edition
Of the AAP Nutrition Handbook. In Press 2006
24 Roy A, Schwarz KB, Hepatitis C in Children. Chapter, Hepatitis C Choices, 4th
Edition
Publisher In press 2006 –
25. Schwarz KB. Viral Infection and Oxidative Stress. Invited Review Rivista di Immuno
In preparation
26. Karnsakul W, Schwarz KB. Hepatitis in Remington & Klein: Infectious Disease of the
Fetus and Newborn Child, 7th edition. Elsevier, (In Press) 2009.
27. Clemente MG, Schwarz KB. Hepatitis. General Principles, Pediatrics in Review
2011;32,333.
28. Schwarz KB. Hepatitis C – Not So Indolent in Survivors of Pediatric Cancer?
Highlight/Invited Commentary on “An updated follow-up of chronic hepatitis C after
three decades of observation in pediatric patients by Cesaro et al in Pediatric Blood and
Cancer July 15 2010:55(1) 108-112.
29. Schwarz KB. HCV and the Pediatric Population Advanced Therapy for Hepatitis C,
Edited by Geoff McCaughan, John McHutchison and Jean-Michel Pawlotsky. Wiley-
Blackwell Books. First Edition Chapter 24 p190-195 2012 Blackwell Publishing Ltd.
30. Clemente MG, Schwarz KB. Hepatitis: General Principles, Pediatrics in Review
2011;32;333.
31. Mogul D, Schwarz KB. Curbside Consultation in Pediatric GI: 49 Clinical Questions
2012.
32. Schwarz KB. Management of Chronic Hepatitis B and C Virus Infection in Children: A
2011 Update. Journal of Pediatr Gastro Nurt 54 (1): May 1, 2012.
33. Schwarz KB. From Bilirubin to Biologics: a History of the Johns Hopkins Division of
Pediatric Gastroenterology in Winklestein, J – a History of the Johns Hopkins Childrens
Center In Press 2013.
34. Mogul D and Schwarz KB. Managing Children Infected with Hepatitis C Virus.2013.
-37-
JID J_ID: CLD64 Date: 27-June-12 Page: 1
35. Imteyaz H, Karnsakul W, Levine MA, Burrows PE, Benson J, Hsu S, and Schwarz
Kathleen B. An Unusual Case of Hypothyroidism. Clinical Problem Solving
36. Schwarz Kathleen B Idiopathic Neonatal Hepatitis and Congenital Infections. Chapter in
Murray KM and Horslen S. Childhood Liver Diseases. In press 2013
37. Karnsakul and Schwarz KB. Metabolic Disorders in the Older Child. Chapter in Sibal A.
Pediatric Gastroenterology, Hepatology, and Nutrition. In Press 2013
XIV. PUBLISHED ABSTRACTS
1. Schwarz KB, Alpers DH and Karl I, Ammonia metabolism by isolated perfusion ileum.
Gastro 72:A105/1128, 1977 (Presented to the American Gastroenterology Association,
April, 1977, Toronto, Canada).
2. Schwarz KB, Zimmerman DC, Zahn M, Alpers DM and Avioli LV, Mechanism for sex
differences in antacidinduced phosphate depletion (abstract). (Proceedings of the Annual
Meeting of the Midwest Society for Pediatric Research - October 30-31, 1979,
Cincinnati, Ohio).
3. Schwarz KB, Witztum J, Schonfeld G and Grundy S, Influence of age on cholesterol
synthesis in children with homozygous familial hypercholesterolemia (HCH). (Midwest
Society for Pediatric Research, November, 1978, Chicago, IL). J Pediatr 96:160, 1980.
4. Schwarz KB, Ternberg JL, Bell MJ, Keating S, and Keating JP, Sodium balance in the
infant ileostomate. (Presented at the Society for Pediatric Research, San Francisco,
4/29/81 Poster Session). #635 Pediatr Res 1981;15:546.
5. Schwarz KB, Karl IE, and Alpers DH, Effect of intraluminal cation exchange resin on
excretion of ammonia in rat ileum. San Francisco, #634 Pediatr Res 1981;15:546.
6. Schwarz KB, Zimmerman DC, Zahn M, Alpers DH, and Avioli LV, Mechanisms for sex
differences in antacid-induced phosphate depletion. San Francisco, #636 Pediatr Res
1981;15:546.
7. Schwarz KB, Gurevitz M, and Karl IE, Hypophosphatemia in Reye's Syndrome. Pediatr
Res 1981;65:33.
8. Gurevitz M, Schulze I, deMello E, and Schwarz KB, Reye's Syndrome model in rats with
phosphorus (P4). Pediatr Res 1982;16:164A.
-38-
9. Squires JE, Keating JP, Schwarz KB, Squires RH, Haymond MW, Devivo DC, and
Rodey G, HLA phenotypes in Reye's Syndrome patients. Pediatr Res 1982;16:178A.
10. Schwarz KB, Gurevitz M, Kanjanajjulpan P, Ylagan M, Schonfeld G, and Fitch CD,
Decreased plasma vitamin E suggests role for hepatic lipid peroxidation in Reye's
Syndrome. Pediatr Res 1983;17:200A.
11. Gurevitz M, Schulze I, Swierkosz E, and Schwarz KB, Altered phosphate metabolism as
a possible link between influenza virus infection and Reye's Syndrome: Effect of
influenza virus on phosphate uptake in epithelial cell culture. Pediatr Res 1983;17:217A.
12. Coyne WH, Erickson SM, Ylagan M, and Schwarz KB, Nutritional assessment in infants
with diarrhea. Pediatr Res 1993;17:186A.
13. Schwarz KB, Keating JP, Kanjananggulpan P, and Fitch CD, Altered erythrocyte
malondialdehyde (RBC/MDA) formation in Reye's Syndrome. Clin Res 1984;32:810A.
14. Schwarz KB, and Bracamontes J, Erythrocyte malondialdehyde (RBC-MDA) formation
during hepatic lipid peroxidation. Hepatology 1984;4:1062.
15. Schwarz KB, Larroya S, Kohlman L and Morrison A. Increased erythrocyte phospholipid
arachidonic acid in Reye's Syndrome (RS). Clin Res 1985;33:A906.
16. Mahanty S, and Schwarz KB. Possible pro-oxidants in hepatic microsomes from a
mouse model of Reye's Syndrome. Hepatology 1985;5:1012.
17. Schwarz KB, Larroya S, Kohlman L, and Morrison A, Increased erythrocyte
phospholipid arachidonic acid in Reye's Syndrome. Pediatr Res 1986;20:334A.
18. Mahanty S, Arey B, and Schwarz KB Aspirin stimulates malondialdehyde production in
mouse liver microsomes. Pediatr Res 1986;20:244A.
19. Schwarz KB, Arey BJ, and Mahanty S. Iron chelation by aspirin (ASA) as a possible
mechanism for ASA-induced malondialdehyde (MDA) production in mouse liver
microsomes. Hepatology 1986;6:1228.
20. Sippel CJ, Cockrell R, and Schwarz KB Influenza virus alters hepatic mitochondrial
oxygen consumption utilizing electron transferring dyes in a mouse model of Reye's
syndrome. Pediatr Res 1987;21:277A.
21. Larroya S, and Schwarz KB Influenza virus alters hepatic mitochondrial lipids in a mouse
model of Reye's Syndrome. Pediatr Res 1987;21:271A.
22. Schwarz KB and Vogler C. Effect of virus preparation on hepatic histopathology in
influenza B virus-treated mice. Ped Res 1998;23:312A.
-39-
23. Shah MC, Weber TR, Connors RR, Hermann VM, Stockmann SM, and Schwarz KB
Nitrogen balance in newborns treated with extra corporeal membrane oxygenation
(ECMO) Pediatr Res 1988;23:313A.
24. Schwarz KB. Effect of iron and desferrioxamine on malondialdehyde production in Hep
G2 cells. Hepatology; 1988;639.
25. Schwarz KB and Seligman P. Effect of Influenza B Virus on Fe-transferrin Uptake by
Hep G2 Cells. Gastroenterology 1989;96:A658.
26. Schwarz KB, Moore TJ, Willoughby RE, and Yolken RH. Growth of Rotaviruses in a
Human Liver Cell Line. Society for Pediatr Res, 1989;25:728.
27. Schwarz KB, Moore TJ, Willoughby RE, and Yolken R. Hep G2 Cells Support
Rotavirus Infection. Hepatology 1989;9: October.
28. Refat M, Moore TJ, Perman JA, and Schwarz KB. Breath Ethane as a Noninvasive
Biomarker of Vitamin E Status in Children. Hepatology, 1990;12;369.
29. Schwarz KB and Korba B. Desferrioxamine (DF) inhibits hepatitis B virus (HBV) virion
production by Hep G2(2.2.15) cells. Hepatology 1990;12:540.
30. Schwarz KB, Beharens P, and Korba B. Inhibition of hepatitis B virus replication in
2.2.15 cells by two different microalgal extracts. Hepatology 1991;14;4:278.
31. Schwarz KB, Moore TJ, Clemens MD, and Seligman P. Influenza B virus promotes lipid
peroxidation (LP) in Hep G2 cells via effects on iron metabolism. Hepatology
1991;14;4:335.
32. Schwarz KB, Cox JM, Sharma SA, Clements L, Humphrey JR, and Witter FA.
Deficiencies of multiple antioxidant nutrients in inner city pregnant women despite
alleged intake of prenatal vitamins. Pediatr Res 1992;31.
33. Schwarz KB, Cox JM, Sharma SA, Witter FA, Perman JA, Sehnert SS, and Risby TH.
Dietary fat intake and serum carotene correlate positively with breath ethane during
pregnancy. Pediatr Res 1992;31:295A.
34. O'Gorman MA, Sharma S, Tennant BC, Gerin JL, Groopman JD, and Schwarz, KB.
Lipid peroxidation and oxidative DNA damage in woodchuck hepatitis virus (WHV) -
infected hepatocytes. Presented AASLD & NASPGN Chicago IL, November 1992,
Hepatology 1992;16;2:159A.
35. Cox JM, Wilhelm J, Machado AA, and Schwarz, KB. Selenium deficiency in children
with chronic liver disease. Hepatology 1992;16;2:79A.
-40-
36. Schwarz, KB, McCaskill QE, Cox JM, and Risby TH. Utility of breath pentane as a
non-invasive index of liver function in children. Presented NASPGN Nov, 1992,
Chicago IL, Hepatology 1992;16;2:237A.
37. Schwarz, KB, Xoc JM, Sharma S, Witter F, Perman JA, Sehnert S, and Risby TH.
Elevation of breath ethane in pregnant women who smoke. Presented Society for
Pediatric Research, Washington, DC, May, 1993, and International Conference on
Critical Aspects of Free Radicals in Chemistry, Biochemistry, and Medicine, Vienna,
Australia, February, 1993.
38. Schwarz, KB, Moore TJ, Sharma S, Lederman H. Aspirin, influenza B virus, and
endotoxin-activated macrophages depress mitochondrial respiration in Hep G2 cells.
Hepatology 1993; 18;4:332A.
39. O'Gorman MA, Fivush BA, Colombani PM, Burdick JF, Schwarz, KB. Proximal renal
tubular acidosis secondary to FK506. Hepatology 1993;18;4:339A.
40. Ramos AG, Mitchell SE, Colombani PM, Schwarz, KB. Severe gastrointestinal bleeding
(GIB) post liver transplantation (LT) in infants. Hepatology 1993;18;4:1139A.
41. Rosensweig J, Sharma S, Schwarz, KB. Lipid emulsion stimulates collagen synthesis in
3T3 Fibroblasts. Mead Johnson Pediatric Gastroenterology Fellows Symposium. Fort
Lauderdale FL 1994.1
42. Yokois NU, Perlman EJ, Colombani P, Wise B and Schwarz, KB. An Atypical
Presentation of Kaposi Sarcoma In An Adolescent Orthotopic Liver Transplant Patient. J
Pediatr Gastr Nutr 1995;21(3):356.
43. Rosensweig J, Rosenstein B and Schwarz KB. Plasma Transforming Growth Factor Beta
1 (TGFß1) Is Reduced In Cystic Fibrosis (CF) Liver Disease (CFLD) But Elevated In
Advanced CF Pulmonary Disease (CFPD). J Pediatr Gastro Nutr. 1995; 21(3):360.
44. Schwarz KB, Hesterberg L, Boitnott J, Casella J and Dover G. Safety and Utility of
Percutaneous Liver Biopsy (PLB) in Hemophiliac Children with Hepatitis C(HCV).
Hepatology 1995; 22(4):276A.
45. Ogburn P, Kanayama M, Van Winter, J, Holman R, and Schwarz, KB. Changes in
Circulating Long Chain Essential Fatty Acids (LCEFA) in Normal Human Pregnancy.
Am J Obstet Gynecol 1996;174(1):375.
46. Schwarz KB, Sharma S, Sitzman J, Klein A, Yager J, Abrams R, Kew M and Groopman
J. Role of Oxidative DNA Damage in Hepatitis B Virus (HBV) Hepatocarcinogenesis.
Hepatology 1996;24(4):469A.
47. Schwarz KB, Sharma S, Cox J, Isola J, Hill K, and Burk R. Decreased plasma
-41-
selenium and selenoprotein P in children with chronic liver disease. Hepatology.
Presented AASLD 1997
48. Schwarz KB, Stamato L, Sharma S, Casella J, Perlman E, Boitnott J and Thomas D.
Response to alpha-interferon(IFN) therapy in hemophiliac children(HC) with hepatitis
C(HCV). Hepatology 1997; 26(4): Pt. 2 419A.
49. Zellos A, Thomas D, Perlman J, Boitnott J and Schwarz KB. Liver pathology in a
cohort of hepatitis C virus (HCV) infected children. J Pediatr Gastroenterol Nutr
1998;26 (5):A202. Poster presentation in the ESPGHAN-NASPGN 5th
Joint Meeting: Toulouse, France, May 1998.
50. Zellos A, Thomas D, Sharma S, Mocilnikar C, Stamato L, Perlman E, Boitnott J, Casella
J and Schwarz KB. Response to interferon alpha-2b therapy in children with hepatitis C
virus (HCV) infection. Acta Gastro-Enterologica Belgica 1998; 61(2):A253. Oral
presentation in AViral Hepatitis throughout Infancy to Adulthood@ Meeting: Brussels,
Belgium, May 1998.
51. Flinn IW, Lemas MV, Noffsinger LE, Fabian D, Yang J, Krone C, Post L, Tran T,
Davis-Sproul LE, Wright S, Schwarz KB, Colombani PM, Orentas RJ, Noga SJ and
Ambinder RF. Phase I dose-escalation trial of partially-matched and haploidential EBV
cytotoxic T lymphocytes in patients with EBV malignancies. 8th International Meeting
of the EVC-Association in Stockholm, Sweden, June 12-16, 1998.
52. Zellos A, Thomas D, Boitnott J, Perlman E, Casella J and Schwarz KB. High viral load
and mild liver injury in young hemophiliacs compared to other children with hepatitis C
virus (HCV) infection. Hepatology 1998; 28(4):A796.
Poster presentation at the AASLD Meeting, Chicago, October 1998.
53. Prabhakaran BA, Lau HT, Wise B, Schwarz KB and Colombani, PM. Incidence of
allergic symptoms in pediatric liver transplant recipients treated with tacrolimus based
immunosuppression. Presented 1999 Surgical Section of American Academy of
Pediatrics.
54. Zellos A, Mocnilkar C and Schwarz KB. Autoimmune hepatitis in patients with
preexisting liver disease. (NASPGN, Denver, Co October 1999).
55. Cohen M, Wise B, Stamato L, Colombani P and Schwarz KB. Utility of liver biopsy
culture in pediatric liver transplant recipients. (NASPGN 1999).
56. Darbari A, Schwarz KB, and Sabin K. Epidemiology of primary and secondary hepatic
malignancies in U.S. children, 1975-1996. (NASPGN 1999)
57. Zellos A, de Almeida A, Karp CL, Jones L, Thomas Dl and Schwarz KB. Decreased
interleukin-2 and interleukin-4 secretion in children with hemophilia and hepatitis C virus
infection. (AASLD 1999).
-42-
58. Darbari A, Sabin KM, Shapiro CW and Schwarz KB. Epidemiology of primary hepatic
Malignancies in U.S. Children1973-1996. Hepatology 1999; 30(4)2:71A.
59. Schwarz KB, Kew MC, Klein AS, Abrams RA, Sitzmann JV, Jones L, Sharma S, Bacon
BR, Di Bisceglie AM, Groopman JD. Increased hepatic oxidative DNA damage in
patients with hepatocellular carcinoma. (AASLD 1999) Dig Dis Sci 2001;46(10):2173-8.
60. Darbari A, Schwarz KB, Sabin K. Epidemiology of hepatocellular carcinoma in U.S.
children, 1973-1996. (AASLD 1999).
61. Flinn IW, Lemas MV, Yang J, Murray PG, Post L, Eby L, Fabian D, Noga S, Mann RB,
Krone C, Ma H, Cottler-Fox M, Schwarz KB, Colombani P, Orentas RJ and Ambinder
RF. EBV adoptive T cell therapy with partially HLA-matched donors is not associated
with graft-versus-host disease (GVHD), American Society of Hematology 1999.
62. Jacobson KR, Murray KF, Zellos A, Schwarz KB. Analysis of interferon
monotherapy trials in children with HCV. World Congress August 5-9, 2000
Boston, MA. J Pediatr Gastroenterol Nutr. 2002;34(1):52-8.
63. Zellos A, DeAlmeida A, Karp CL, Jones L, Hollomon E, Casella JF, Schwarz KB.
Decreased interleukin-12 secretion in children with hemophilia and Hepatitis C virus
infection. Hepatology 51st Annual Meeting, 32:284A 2000.
64. Darbari A, Kan J, Cameron D, Sena L, Schwarz KB. Utility of cardiac angiography
during upper gastrointestinal endoscopy to diagnose "pseudo vascular ring". World
Congress - August 5-9, 2000, Boston, MA.
65. Colombani PM, Prabhakaran K, Wise B, Lau HT, Schwarz K. Incidence of allergic
symptoms in pediatric liver transplant recipients treated with tacrolimus based
Immunosuppression. First Congress of the International Transplant Association,
Venice, Italy, August 23-25, 2000.
66. Colombani PM, Prabhakaran K, Schwarz K, Wise B, Lau HT. Comprehensive
prospective management of biliary atresia. First Congress of the International
Transplant Association, Venice Italy, August 23-25, 2000
67. Schwarz KB, Alford MK, Barker PB. Utility of proton magnetic resonance spectrostocpy
(PMRS) in children with liver failure. Poster presentation AASLD, Dallas Texas, November
2001
68. Li DY, Oelke M, Schneck J, Schwarz KB. Generation of HCV peptide-specific CD8+ cytotoxic
T lymphocytes and their visualization by a divalent peptide-HLA A2-lg complex. Poster
presentation AASLD, Dallas Texas, November 2001.
-43-
69. Schwarz KB, Sztam K, Zellos A, Alford MK. Epidemiology of chronic hepatitis C virus (HCV)
infection in children born after 1990 and referred to a university clinic. AASLD Dallas, Texas,
November 2001. To be published Hepatology October 2001.
70. Schwarz KB, Ichord RN, Reimschisel TY, Alford MK, Barnes YP, Pulsifer M.
Neuropsychological profiles of children with end-stage liver disease (ESLD) pre-and post
transplant. AASLD, Dallas Texas, November 2001. To be published Hepatology, October 2001.
71. Schwarz KB, Rosensweig S, Sharma S, Jones L, Durant M, Potter C and Narkewicz MR.
Increased plasma transforming growth factor beta 1 in patients with severe pulmonary disease
secondary to cystic fibrosis. Poster presentation 14th
annual NASPGN meeting, Orlando
Florida, October 2001.
72. Li DY, Boitnott JK, and Schwarz KB. Human herpes virus-6 (HHV-6): cause of fulminant
hepatic failure or “innocent bystander”. Poster presentation 14th
NASPGN Annual meeting,
Orlando Florida, October 2001.
73. Albayram F, Stone K, Nagey D, Schwarz KB, Blakemore B. Alagille syndrome:
prenatal diagnosis and pregnancy outcome. Fetal Diag & Ther 2002;17(3):182-4.
74. Balistreri W, Schwarz KB. Viral Hepatitis. J Pediatric Gastroenterology and Nutrition
35:S29-S32 July 2002
75. Li DY, Scheimann A, Songer G, Horwitz M, Resar L, Schwarz KB. A rare case of
enteritis necroticans caused by clostriduium perfringens type C and recurrent
enterocutaneous fistula E in a child with cyclic neutropenia. Poster presentation
NASPGHAN 15th
Annual Meeting, San Antonio, Texas, October 2002.
76. Schwarz, KB, Mohan P, Narkewicz M, Molleston JP, Te HS, Hu S, Sheridan S, Lamb M,
Pappas SC and Harb G. The Safety, Efficacy and Pharmacokinetics of Peginterferon Alpha-2a
(40KD) In Children with Chronic Hepatitis C. Gastroenterology, April 2003 Vol
124(4) Suppl 1-Page A-700 DDW Orlando, Fla May 2003. Submitted JPGN 5/06
77. Oliva-Hemker M, Paidas C, Campbell A, Lindyberg K, Schwarz KB, Zambidiset E.
Malignant mesothelioma mimicking inflammatory bowel disease. J. Pediatr
Gastroenterol Nutr (In Press)
78. Li DY, Scheimann A, Songer G, Horowitz Ml, Resar L, Schwarz KB. A Rare Case of
Enteritis Necroticans Caused by Clostridium Perfringens Type C and Recurrent
Enterocutaneous Fistulae in a Child with Cyclic Neutropenia. NASPGHAN Annual
Meeting , San Antonio, Texas, October. 2002
79. Schwarz KB, Stover B Staples A, Barnes PY. Low HBV Vaccine Coverage of Homeless
Children in Baltimore: US Public Policy Implications? Hepatology 53rd
Annual Meeting,
Boston, Mass, 2002. Hepatology 36(4):Pt.2;368A Oct. 2002 .
-44-
80. Schwarz KB, Barnes, PY, Stover B, Bowser Y, Bareta J.Application of a Fingerstick Technique
to Survey Hepatitis C Virus (HCV) Epidemiology in Homeless Children and Their Caregivers in
Baltimore City. Hepatology Annual Meeting, Boston, Mass. November, 2002. Hepatology
36(4)Pt. 2, 565A; 2002.
81. Schwarz KB, Lee J, Stover B, Barnes PY, Bowser Y, Bareta J. Impact of a Culturally
Appropriate Educational Video on Acceptance of Hepatitis B Vaccine by Homeless Families. .
Hepatology Annual Meeting, Boston, Mass. Hepatology 36(4);Pt. 2:621A 2002.
82. Li DY, Byrnes A, Mocilnikar C, Schwarz, KB. The Magnitude of IFN-Driven IFN
Production Correlates with Sustained Hepatitis C Viral Clearance in Children Treated
with Pegylated IFN 2(40KD). NASPGHAN Annual Meeting, October 2-5, 2003,
Montreal, Quebec.
83. Castiglia, Schwarz KB. An Extended, Stratified, Follow-On Study in Children with
chronic Hepatitis B (CHB) Who Have Completed Previous Lamivudine Studies.
AASLD Annual Meeting, October 24-28 2003, Boston. HEPATOLOGY 38(4)Suppl 1, P 711A
2003.
84. Schwarz KB, Garrett BM, Barnes PY, Ashe S, Bowser YD and O’Driscoll P.
High Prevalence of Hepatitis C Virus (HCV) in Homeless Caregivers in Baltimore.
Presented at the 2nd
World Congress of Pediatric Gastroenterology, Hepatology and
Nutrition, July 2004, Paris, France.
85. Schwarz KB. Hepatitis C Viral Kinetics in Children Treated with PegIGN Alfa-2A
Presented AASLD on October 31, 2004
86. Schwarz KB. Inadequate Hepatitis B Vaccine Coverage in Older Homeless Children
In Baltimore. DDW Annual Meeting, New Orleans, LA 2004 Oral Presentation
World Congress of Pediatric Gastroenterology, Hepatology and Nutrition, Paris, France, July
2004.
87. Schwarz, KB. Cost Effectiveness of Living Related Liver Transplantation
AASLD Annual Meeting Boston, MASS 2004 Hepatology
88. Shneider B, Brown M, Sokol R, Whitington P, Schwarz K, Squires R, Shepherd R,
Rosenthal P, Robuck P, and BARC. A Multi-Center Analysis of Outcome at 24 Months
of Age in Children with Biliary ATresia in the United States. Presented at the American
Association for the Study of Liver Diseases, 55th
Annual Meeting, Boston, MA Hepatology
2004 Oct;40(S4):201A.
89. Schwarz KB, Garrett B. “ High Prevalence of Obesity in Homeless Baltimore Children and
their Caregivers” Poster Presentation at Annual NASPGHAN Meeting, Salt Lake City, UT
October , 2005.
-45-
90. Murray KF, Barton B, Gonzalez-Peralta RP, Rodrigue J, Shepherd J, Schwarz, KB.
Development of a Large Scale Multi-Center Randomized Center Trial of Children with
Chronic Hepatitis C Virus Infection PEDS C. NASPGHAN Meeting, Salt Lake City, UT
October, 2005. JPGN 41(4) October 2005 p 524.
91. Sullivan, S, Schwarz KB. Management of a Type III Choledochal Cyst. Poster
Presentation at NASPGHAN Meeting, Orlando City, FL. October 19-22, 2006.
92. Schwarz KB. “Positive Impact of Hepatitis B(HB) Video on HB Vaccine Coverage in
Homeless Children and Adolescents in Baltimore: Results of a Randomized Controlled Trial”
Abstract/Poster Presentation AASLD 57th
Annual Meeting – Boston, MA Oct. 27-31, 2006
93. Goodman Z, Makhlouf H, Liu L, Balistreri W, Gonzalez-Peralta R, Haber B, Jonas M, Mohan
P, Molleston J, Murray K, Narkewicz M. Rosenthal P, Smith L, Schwarz KB. Pathology of
Chronic Hepatitis C in Children: Liver biopsy findings in the PEDS C Trial. Abstract/Poster
Presentation AASLD 57th
Annual Meeting – Boston, MA Oct. 27-31, 2006
94. Rodrique JR, Balistreri W, Haber B, Jonas M, Mohan P, Molleston JP, Murrary KF,
Narkewicz MR, Rosenthal P, Smith LJ, Schwarz KB. Impact of Hepatitis C Virus (HCV)
Infection in Children: Quality of Life, Emotional, and Cognitive Outcomes. Abstract/Poster
presentation AASLD 57th
Annual Meeting – Boston, MA Oct. 27-31, 2006
95. Sokol RJ, Bezerra J, Haber B, Karpen S, Perlmutter D, Rosenthal P, Schwarz K, Shepherd R,
Shneider B, Whitington P, Brown M, Magee J, Robuck P, and Hoofnagle J for BARC. Biliary
Atresia Research Consortium (BARC): NIH funded network to advance knowledge and improve
care and outcomes in biliary atresia. Presented at Poster Session of NIH Workshop on Screening
and Outcomes in Biliary Atresia, Bethesda, MD., Sept. 11, 20006.
97. Narkewicz M, Olio DD, Karpen SJ, Krug S, Murray KF, Schwarz KB. et al. Pattern of
diagnostic evaluation for the causes of pediatric acute liver failure (PALF): Opportunities for
Quality Improvement. (AASLD Annual Meeting Boston, Mass Nov 2-6, 2007).
98. Shneider B, Shepherd R, Magee J, Bucuvalas JC, Haber B, Karpen SJ, Rosenthal P, Schwarz
KB, et al. Discriminating features of biliary atresia – A prospective multi-centered analysis.
(AASLD Annual Meeting Boston, Mass Nov 2-6, 2007).
99. Haber B, Balistreri WF, Bartob B, Gonzalez-Peralta RP, Goodman ZD, Jonas MM, Lobritto SJ,
Mohan P, Molleston JP, Murray KF, Narkewicz M, Robuck PR, Rosenthal P, Schwarz KB.
HCV autoimmunity in a U.S. multi-center cohort of treatment naϊve children. (AASLD Annual
Meeting Boston, Mass Nov 2-6, 2007).
100. Locke JE, Stewart ZA, Singer AL, Warren DS, Schwarz K, Maley WR, Montgomery RA,
Cameron AM. Hepatic artery thrombosis after pediatric liver transplantation: identification and
characterization of a novel risk factor. XXII International Congress of The Transplantation
Society, Sydney, Australia, mini-oral presentation
-46-
101. Locke JE, Stewart ZA, Singer AL, Warren DS, Schwarz K, Maley WR, Montgomery RA,
Cameron AM. Hepatic artery thrombosis after pediatric liver transplantation: identification of a
novel risk factor. 94th Annual Clinical Congress of the American College of Surgeons, San
Francisco, California, mini-oral/poster presentation.
102. Rosenthal P, Mohan P, Barton B, Robuck PR, Schwarz KB. Incidence of Neutropenia and
Impact on Sustained Virological Response (SVR) in Children and Adolescents with Chronic
Hepatitis C Treated with Peginterferon with or without Ribavirin: The PEDS-C Experience.
Hepatology 48(4)1623:1031A AASLD San Francisco, CA 2008
103. Schwarz KB, Gonzalez-Peralta RP, Murray KF, Molleston JP, Haber B, Jonas MM, Mohan P,
Balistreri WF, Rosenthal P, Narkewicz MR, Smith LJ, Robuck PR, Barton B. Peg Interferon
with or without Ribavirin for Chronic Hepatitis C in Children and Adolescents: Final Results of
the PEDS-C Trial Hepatology 48(4):242;418A AASLD San Francisco, CA 2008.
104. Haber B, Fredericks EM, Magee J, Bezerra JA, Karpen SJ, Kerkar N, Rosenthal P, Schwarz KB,
Shepherd R, Shneider BL, Whitington PF, Robuck PR, Sokol RJ. Predictors of
neurodevelopmental outcome in non-transplanted children with biliary atresia at one year of age.
Hepatology 48(4) 1616:1028A AASLD San Francisco, CA 2008.
105. Schwarz KB, Shepherd RW, Magee J, Rosenthal P, Mack C, Raghumathan T, Bezerra JA,
Haber B, Karpen SJ, Shneider BL, Suchy FJ, Whitington PF, Robuck PR, Sokol RJ. Clinical
Demographic Features of Three Major Biliary Atresia Phenotypes in The BARC study.
Hepatology 48(4) 1615:1028A AASLD San Francisco, CA 2008.
106. Roy A, Colombani P, Lay H, Wilson L, Intihar P, Reeb B, Schwarz KB.
Two Decades of Experience with Pediatric Living Related and Deceased Donor Liver
Transplant. Hepatology 48(4):101;350A AASLD San Francisco, CA 2008.
107. Narkewicz M, Rosenthal P, Schwarz KB, Drack A, Margolis T, Repka M.
Opthalmologic Complications in Children with Chronic Hepatitis C Treated with Pegylated
Interferon: The PEDS-C Experience. NASPGHAN San Diego, CA 2008.
108. Clemente MG, Schwarz KB. Infection of human cholangiocytes and human hepatocytes with
SA11 rotavirus (The virus used for the murine biliary atresia model).
STC Conference on Cholangiocyte Biology 2008 Atlanta, GA.
109. Schwarz KB, Dell Olio D, Lobritto S, Lopez J, Rodriquez-Baez N, Yazigi N, et al.
An Analysis of Viral Testing in non-APAP Pediatric Acute Liver Failure (PALF)
Digestive Disease Week May 30- June 4, 2009 Chicago, Il.
110. Haber BA, Block JM, Jonas MM, Karpen SJ, London WT, McMahon B, Murray KF, Narkewicz
MR, Rosenthal P, and Schwarz KB. Management of Chronic Hepatitis B in Children in North
America: Report of a Workshop. Submitted to Pediatrics 2009.
111. Vasilescu A, Paranjape S, Karnsakul W, Schwarz KB. Design of a Pilot Study to Identify
-47-
Optimum Markers of Liver Fibrosis in Children with Cystic Fibrosis Liver Disease (CFLD)
CFLD clinical research workshop page 48.
112. Shneider BL, Abel R, Raghumathan T, Magee J, Bezerra JA,, Haber B,Karpen SJ,
Rosenthal P, Schwarz KB, Shepherd RW, Suchy FJ, Whitington PF, Robuck PR, and Sokol RJ:
A prospective multi-centered investigation of vitamin supplementation in infants with biliary
atresia: Interim analysis from the biliary atresia research consortium (BARC).
Publication Number: 698 AASLD Boston, MA 2009.
113. Sundaram SS, Fredericks EM, Kamath BM, Haber B, Raghumathan T, Magee JC,
Bezerra JA, Karpen SJ, Kerkar N, Rosenthal P, Schwarz KB, Shepherd RW, Shneider BL,
Whitington PF, Robuck PR, and Sokol RJ: A multicenter cross sectional assessment of quality of
life in biliary atresia patients aged 2-25 years. ID #699 AASLD Boston, MA 2009.
114. Molleston JP, Schwarz KB, Jonas M, Goodman Z, Rodrique J. Autoantibodies and
Autoimmune Disease during the PEDS-C trial. NASPGHAN Annual Meeting, November 12-
14, 2009, National Harbor, MD.
115. Haber BA, Narkewicz M, Schwarz KB. Recommendations for Screening, Monitoring and
Referral of Children with Chronic Hepatitis B in North America: Report of a Workshop
Pediatrics Editorial Office Nov 2009.
116 . Walsh MF, Wang T, Schwarz K, Crawford T, Hirano M, Wong L, Wang J, Cohn
RD. Compound Heterozygosity of the POLG1 Gene Presenting with Liver Failure
and Hypotonia. American Society of Human Genetics (ASHG) Meeting, Hawaii
October 23, 2009 (Accepted for Presentation).
117. Schwarz KB, Valsamakis A, Ballistreri WF, Gonzalez-Peralta RP, Haber B, Jonas MM, Mohan
P, Molleston JP, Murrary KF, Narkewicz M, Rosenthal P, Smith LJ, Rossi SJ, Robuck PR,
Barton B. Early changes in viral load predict sustained viral response (SVR) in the PEDS C
trial. Hepatology 50(4):240;419A AASLD Boston, MA 2009.
118. Jonas MM, Balistreri WF, Gonzalez-Peralta RP, Haber B, Mohan P, Molleston JP, Murray KF,
Narkewicz M, Rosental P, Schwarz KB, Smith LJ, Barton B. Changes in body mass index and
body composition in children treated with peginterferon for chronic hepatitis C in the PEDS-C
trial. Hepatology 50(4):708-636A AASLD Boston, MA 2009.
119. Rodrique JR, Balistreri JR, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz
M, Rosenthal P, Smith LJ, Schwarz KB, Robuck PR, Barton B, Gonzalez-Peralta RP.
Peginterferon alfa-2A with or without ribavirin results in minimal effect on quality of life,
emotional, and cognitive outcomes: results of the PEDS-C trial. Hepatology 50(4):238-418A
AASLD Boston, MA 2009.
120. Shneider BL, Abel RB, Raghumathan T, Magee JC, Bezerra JA, Haber B, Karpen SJ, Rosenthal
P, Schwarz KB, Shepherd RW, Suchy FJ, Whitington PF, Robuck PR, Sokil RJ. A prospective
multi-centered investigation of vitamin supplementation in infants with biliary atresia: interim
-48-
analysis from the biliary atresia research consortium (BARC). Hepatology 50(4):698-631A
AASLD Boston, MA 2009.
121. Sundaram SS, Fredericks EM, Kamath BM, Haber B, Raghumathan T, Magee JC, Bezzera JA,
Karpen SJ, Kerkar N, Rosenthal P, Schwarz KB, Shepherd RW, Shneider BL, Whitington PF,
Robuck PR, Sokol RJ. A multicenter cross sectional assessment of quality of life in biliary
atresia patients aged 2-25 years. Hepatology 50(4):699-632A AASLD Boston, MA 2009.
122. Sokol RJ, Magee JC, Hahn C, Robuck PR, Bezerra JA, Haber B, Karpen SJ, Molleston J, Murray
KF, Narkewicz M, Ng V, Padron-Turmelle Y, Romero R, Rosenthal P, Schwarz KB, Shneider
BL, Suchy F, Teckman J, Wang K, Whitington PF for the CHILDREN. The New Childhood
Liver Disease Research and Education Network (ChiLDREN): A Cooperative Endeavor between
NIDDK, Academic Centers and Patient Advocacy Groups. Presented NASPGHAN National
Harbor, MD Nov. 2009.
123. Clemente MG, Patton JP, Oh E, Anders R, Yolken RH, Schwarz KB. Rotavirus infection of
Human cholangiocytes results in release of IL-6 and IL-8 DDW, AASLD Pediatric Liver
Disease Session, New Orleans, La, May, 2010.
124. Clemente MG, Schwarz KB, Patton JP, Yolken RH, Parashar U, Parashar U, Whitington P,
Raghunathan T, Jiang B, FoyTich KR. Prevalence of acute asymptomatic group A rotavirus
infection in cholestatic infants enrolled in the Biliary Atresia Research Consortium (BARC) .
DDW, AASLD Plenary Session, New Orleans, La, May, 2010
125. Omenetti A, Bass L, Anders R, Clemente MG, Francis H, Guy CD, Shoi SS, Alpini G, Schwarz
K, Whitington P, Diehl AM. Hedgehog pathway drives the acquisition of mesenchymal markers
in ductular cells of patients with biliary atresia. Submitted AASLD 2010.
126. Shneider BO, Abel B, Haber B, Karpen SJ, Magee JC, Romero R, Schwarz KB, Bass L, Kerkar
N, Miethke A, Rosenthal P, Turmelle Y, Kokol RJ. Cross-sectional Multi-center Analysis of
Portal Hypertension in 163 Children with Biliary Atresia. Submitted to AASLD 2010.
127. Clemente MG, Schwarz KB. Rotavirus (RV) infection of Human Cholangiocytes results in
Release of IL-6 and IL-8. NASPGHAN 2010.
128. Clemente MG, Schwarz KB, Patton JP, Yolken RH, Parashar U, Parashar U, Whitington P,
Raghunathan T, Jiang B, FoyTich KR. Prevalence of acute asymptomatic group A rotavirus
infection in cholestatic infants enrolled in the Biliary Atresia Research Consortium (BARC) .
NASPGHAN 2010.
129. Lucas JE, Patel K, Thompson JW, Dubios L, Thompson A, Tillmann H, Clark PJ, McCarthy JJ,
Moseley MA, Schwarz KB, McHutchison JG. Validation of a label-free proteomics predictor of
response to therapy in pediatric CHC patients. Submitted AASLD 2010.
130. Shneider BL, Magee JC, Karpen SJ, Rand E, Markewicz M, Schwarz KB, Whitington PF, et al.
Prospective Multicenter Analysis of Post-operative Total Bilirubin as a Biomarker for Short-term
-49-
Outcome after Hepatoportoenterostomy for Biliary Atresia. AASLD 2011.
131. Ng VL, Haber B, Magee JC, Bezerra JA, Whitington PF, Schwarz K, et al. Health Status of 192
Children with Biliary Atresia Surviving >5 years After Kasai Portoenterostomy with Their
Native Liver: How are They Doing? AASLD 2011.
132. Shneider B, Robuck P, Rosenthal P, Schwarz KB, Karpen SJ, Narkewicz M, Magee J.
"Prospective Multicenter Analysis of Post-operative Total Bilirubin as a Biomarker for Short-
term Outcome After Hepatoportoenterostomy for Biliary Atresia" oral presentation at the 62nd
Annual Meeting of AASLD in San Francisco, California, November 4 - November 8, 2011.
HEPATOLOGY 2011:54;(4)114A.
133. Karnsakul W, Schwarz KB. Financial and Clinical Analysis of Living related Liver
Transplantation in Children: A Single Center Experience. (1136294) AASLD
HEPATOLOGY 2011:54 (4);170A.
134. Ng VL, Haber B, Magee J, Karpen S, Miethke A, Schwarz K, et al. Report from ChiLDREN:
Medical Status of 192 Children with Biliary Atresia Surviving >5 years After Kasai
Portoenterostomy With Their Native Liver. AASLD HEPATOLOGY 2011:43(4);175a.
135. Hourigan SK, Anders RA, Mitchell SE, Schwarz KB, Lau H, Karnsakul W. Protein-losing
enteropathy in an infant with hepatic venous outflow obstruction after liver transplantation.
Presented at NASPGHAN Orlando, Fl 2011.
136. Schwarz KB, Ling S, Rosenthal P, Murray K, Rodriguez-Baez N, Teckman J, Schwarzenberg S,
Li R and Belle SH for the Hepatitis B Research Network (HBRN) Phenotypes of North
American children with hepatitis B virus (HBV) infection. AASLD Annual Meeting, Boston,
Mass.
137. Koeck ES, Iordanskaia T, Devadason C, Rossi C, Anders R, Schwarz K, Nadler EP. .
Integrin Beta-8, but not Beta-5 or -6, Protein Expression is Increased in Livers of Children with
Biliary Atresia. NASPGHAN Orlando, Fl 2012.
138. Schwarz KB. Cost-effective analysis of screening for biliary atresia with the stool color card
(ID# 1734263). Presented at AASLD 2013.
139. Schwarz KB. Seroprevalance of Anti-IgG and Anti-IgM Antibodies to Hepatitis E Virus in Solid
Organ Transplant Recipients at a North American Transplant Center (ID # 1736615. Presented
at AASLD Annual Meeting 2013.
140. Schwarz KB. Determinants of cost in biliary atresia (ID# 1734453) presented at AASLD Annual
Meeting 2013.
141. Bezerra JA, Spino C, MaGee JC, Shneider BL, Rosenthal P, Wang KS, Erlichman J, Haber B,
Hertel PM, Karpen SJ, Kerkar N, Loomes KM, Molleston JP, Murray KF, Romero R, Schwarz,
KB, et al. High-dose corticosteroid therapy following portoenterostomy in infants with biliary
-50-
atresia does not improve outcome: The multi-center, randomized, double-blind, placebo-
controlled START Trial (ID# 1737851). To be Presented AASLD Annual Meeting 2013.
142. Sue P, Pisanic N, Forman H, Heaney C, Schwarz K, Nelson K, Karnsakul W. Variability of
Hepatitis E serologic assays in a pediatric liver transplant recipient: Challenges in the diagnosis
of Hepatitis E infection among at risk individuals. To be presented to NASPGHAN 2013.
143. Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Schwarz KB. A randomized trial of
corticosteroids in infants with biliary atresis: The multi-center START trial. AASLD 2013,
Washington, DC.
144. Jonas M, Schwarz K, Sokal E, Reynolds L, Thiry A, Kelly D. A comparative study of the
antiviral efficacy and safety of entecavir versus placebo in HBeAg-positive pediatric subjects
with chronic hepatitis B. Poster of distinction APASL 2014 (March 12-15, Brisbane Australia.
145. Schwarz, KB. AASLD Washington, DC 2013.
146. Mogul D, Teckman J, Cloonan YK, Schwarz K, MacGregor JM. Drug resistance, basal core
promoter and pre-core stop mutations in a large cohort of North American children with
Hepatitis B: Results for the Pediatric Cohort Study of the NIDDK-Sponsored Hepatitis B
Research Network (HBRN) (1895577), Digestive Disease Week at McCormick Place
Convention Center in Chicago, IL, May 3 - May 6, 2014.
147. Schwarz K. Moleston JP, Jonas MM, Wen J, Murray K, Rosenthal P, Gonzalez-Peralta RP,
Lobritto SJ, Mogul D, Hooper G, Warne C, Thompson B. Long-term Durability of Sustained
Viral Response (SVR) in Children Treated for Chronic Hepatitis C (PEDS C Trial) (1903048)
lecture presentation during Digestive Disease Week, at McCormick Place Convention Center in
Chicago, IL, May 3- May 6, 2014.
148. Sue PK, Pisanic N, Nelson K, Schwarz KB, Heaney C, Montgomery R, Jackson A, Ticehurst J,
Forman M, Valsamakis A, Karnsakul W. Hepatitis E Virus Infection among Solid Organ
Transplant Recipients at a North American Transplant Center. Infectious Disease Society of
America 2014.
149. Ng VL, Haber BH, Magee JC, Miethke A, Murray KF, Michail S, Karpen SJ, Kerkar N,
Molleston JP, Romero R, Rosenthal P, Schwarz KB, Shneider BL, Turmelle YP, Alonso EM,
Sherker AH, and Sokol RJ, on behalf of the Childhood Liver Disease Research and Education
Network (CHiLDREN. Medical Status of 219 Children with Biliary Atresia Surviving Long-
Term with Their Native Livers: Results from a North American Multicenter Consortium.
The Journal of Pediatrics . 2014
150. Kelly D, Jonas M, Schwarz KB, Orasenau D, Reynolds L, Sokal E, Thiry A. Bargaje R, Gupta
K. “A comparative study of the antiviral efficacy and safety of entecavir versus placebo in
HBeAg-positive pediatric subjects with chronic hepatitis B”. Poster presented at APASL 2014.
-51-
151. Sue PK, Pisanic N, Nelson K, Schwarz K, Heaney C, Montgomery R, Jackson A, Ticehurst J,
Forman M, Valsamakis, A, Sanyal A, Karnsakul W. Characteristics of Post Transplantantion
Hepatitis E Virus Infection Amng Solid Organ Transplant Recipients at a North American
Transplant Center. To be presented at AASLD Boston, MA 2014.
152. Hsinghua Sylvia Lin, Sarah Jane Schwarzenberg, Yona Keich Cloonan , Simon C. Ling, Karen
F. Murray, Norberto Rodriguez-Baez, Philip Rosenthal, Jeffrey Teckman, Kathleen B. Schwarz.
Health-Related Quality of Life in Youth with Chronic Hepatitis B in the United States and
Canada: Pediatric Cohort of Hepatitis B Research Network . Dean’s Day Poster Competition,
University of Pittsburgh Graduate School of Public Health. 2015
Recommended